###################################################################################################################################################################
#Enrichment results using 'Biological Process from Gene Ontology (GO)', created by dcGO Enrichment at 30/05/2016 17:04:37 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0023051	regulation of signaling	1	9.20	5.13e-17	4.72e-14	112|425|441|3527	PF00019;PF00020;PF00027;PF00040;PF00057;PF00059;PF00063;PF00072;PF00086;PF00093;PF00094;PF00097;PF00122;PF00130;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00515;PF00564;PF00605;PF00610;PF00611;PF00618;PF00630;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00870;PF00884;PF00969;PF01017;PF01030;PF01291;PF01302;PF01391;PF01392;PF01403;PF01412;PF01437;PF01485;PF01562;PF01585;PF01699;PF01753;PF01833;PF02145;PF02148;PF02177;PF02199;PF02214;PF02218;PF02262;PF02377;PF02434;PF02761;PF02762;PF02865;PF03165;PF03226;PF03489;PF03727;PF03920;PF04868;PF05076;PF05184;PF06920;PF07525;PF07645;PF07653;PF07679;PF07710;PF08232;PF08563;PF09289;PF09324;PF09379;PF09380;PF10358;PF10401;PF10409;PF10608;PF12470;PF12548;PF12763;PF12783;PF12796;PF12924;PF12925;PF13353;PF13405;PF13637;PF13639;PF13716;PF13855;PF13905;PF14324;PF14429
Group	GO:0010646	regulation of cell communication	1	8.37	4.13e-14	1.90e-11	88|425|336|3527	PF00019;PF00020;PF00027;PF00040;PF00057;PF00059;PF00063;PF00072;PF00086;PF00093;PF00122;PF00130;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00618;PF00630;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00870;PF00884;PF00969;PF01017;PF01030;PF01291;PF01302;PF01391;PF01392;PF01403;PF01437;PF01485;PF01585;PF01699;PF01833;PF02145;PF02214;PF02218;PF02262;PF02434;PF02761;PF02762;PF02865;PF03165;PF03226;PF03727;PF03920;PF04868;PF05076;PF07525;PF07645;PF07653;PF07679;PF07710;PF08563;PF09289;PF09379;PF09380;PF10358;PF10409;PF10608;PF12470;PF12548;PF12763;PF12796;PF13353;PF13405;PF13637;PF13639;PF13716;PF13855;PF13905;PF14324
Group	GO:0048583	regulation of response to stimulus	1	8.04	8.28e-14	2.54e-11	115|425|503|3527	PF00019;PF00020;PF00027;PF00040;PF00057;PF00059;PF00063;PF00072;PF00086;PF00093;PF00094;PF00097;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00373;PF00400;PF00452;PF00515;PF00564;PF00605;PF00610;PF00611;PF00618;PF00630;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00870;PF00884;PF00969;PF01017;PF01030;PF01217;PF01302;PF01391;PF01392;PF01403;PF01412;PF01437;PF01476;PF01485;PF01562;PF01585;PF01602;PF01753;PF01833;PF02145;PF02148;PF02177;PF02199;PF02214;PF02218;PF02262;PF02377;PF02434;PF02760;PF02761;PF02762;PF02865;PF03165;PF03226;PF03489;PF03920;PF04868;PF05076;PF05184;PF06733;PF06920;PF07525;PF07534;PF07645;PF07653;PF07679;PF07686;PF07710;PF08232;PF08246;PF08563;PF09289;PF09379;PF09380;PF10358;PF10401;PF10409;PF11648;PF12470;PF12548;PF12763;PF12796;PF12924;PF12925;PF13353;PF13405;PF13637;PF13639;PF13716;PF13855;PF13905;PF14324;PF14429
Group	GO:0019538	protein metabolic process	1	7.60	2.69e-13	6.19e-11	168|425|869|3527	PF00019;PF00027;PF00040;PF00045;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00094;PF00097;PF00122;PF00130;PF00133;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00246;PF00254;PF00258;PF00266;PF00270;PF00271;PF00373;PF00385;PF00400;PF00413;PF00415;PF00432;PF00452;PF00515;PF00530;PF00534;PF00535;PF00557;PF00564;PF00583;PF00605;PF00611;PF00622;PF00630;PF00651;PF00667;PF00675;PF00688;PF00702;PF00749;PF00754;PF00757;PF00780;PF00789;PF00884;PF00899;PF00989;PF01030;PF01088;PF01302;PF01336;PF01391;PF01426;PF01433;PF01471;PF01485;PF01530;PF01546;PF01562;PF01663;PF01753;PF01814;PF01841;PF02008;PF02148;PF02177;PF02182;PF02185;PF02214;PF02225;PF02259;PF02260;PF02262;PF02359;PF02434;PF02518;PF02671;PF02761;PF02762;PF02824;PF02865;PF03133;PF03155;PF03165;PF03256;PF03485;PF04137;PF04389;PF04557;PF04558;PF04721;PF04756;PF04810;PF04811;PF04818;PF04868;PF05020;PF05021;PF05024;PF05033;PF05193;PF05207;PF05773;PF05922;PF06480;PF07645;PF07653;PF07679;PF07686;PF07687;PF07707;PF07973;PF08064;PF08246;PF08288;PF08295;PF08367;PF08662;PF08736;PF08773;PF08926;PF09247;PF09379;PF09380;PF09409;PF10250;PF10401;PF10409;PF10436;PF10585;PF11701;PF11717;PF11816;PF12548;PF12697;PF12796;PF12894;PF12895;PF12906;PF12924;PF12925;PF13344;PF13353;PF13405;PF13519;PF13589;PF13599;PF13620;PF13637;PF13639;PF13733;PF13831;PF13832;PF13848;PF13855;PF13891;PF14324
Group	GO:0043412	macromolecule modification	1	7.62	7.09e-13	1.09e-10	128|425|602|3527	PF00019;PF00027;PF00063;PF00076;PF00085;PF00094;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00240;PF00246;PF00254;PF00258;PF00270;PF00271;PF00373;PF00385;PF00400;PF00415;PF00432;PF00515;PF00530;PF00534;PF00535;PF00557;PF00564;PF00567;PF00583;PF00605;PF00611;PF00622;PF00630;PF00651;PF00667;PF00688;PF00754;PF00757;PF00780;PF00899;PF00989;PF01030;PF01088;PF01189;PF01302;PF01426;PF01485;PF01530;PF01585;PF01663;PF01753;PF01814;PF01841;PF02008;PF02148;PF02177;PF02182;PF02185;PF02214;PF02225;PF02259;PF02260;PF02434;PF02518;PF02671;PF02865;PF03133;PF03155;PF03165;PF03256;PF04389;PF04408;PF04756;PF04762;PF04810;PF04811;PF04818;PF04868;PF05024;PF05033;PF05207;PF05773;PF06464;PF07645;PF07653;PF07679;PF07707;PF08032;PF08064;PF08210;PF08288;PF08295;PF08736;PF08926;PF09247;PF09379;PF09380;PF10250;PF10401;PF10409;PF10436;PF10585;PF11717;PF11816;PF12047;PF12148;PF12697;PF12796;PF12872;PF12894;PF12895;PF12906;PF12924;PF12925;PF12933;PF12934;PF13344;PF13599;PF13637;PF13639;PF13733;PF13831;PF13832;PF13855;PF13891;PF14324
Group	GO:0048519	negative regulation of biological process	1	7.59	5.99e-13	1.09e-10	140|425|681|3527	PF00019;PF00024;PF00057;PF00072;PF00076;PF00086;PF00093;PF00097;PF00122;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00241;PF00254;PF00258;PF00270;PF00271;PF00307;PF00349;PF00350;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00530;PF00564;PF00567;PF00605;PF00611;PF00622;PF00630;PF00642;PF00651;PF00667;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00789;PF00870;PF00884;PF00969;PF01017;PF01030;PF01088;PF01291;PF01302;PF01335;PF01391;PF01392;PF01403;PF01426;PF01477;PF01562;PF01585;PF01602;PF01624;PF01699;PF01753;PF01833;PF01909;PF02145;PF02148;PF02177;PF02181;PF02214;PF02259;PF02260;PF02262;PF02463;PF02671;PF02761;PF02762;PF02865;PF02881;PF03165;PF03167;PF03226;PF03727;PF03920;PF05033;PF05076;PF05773;PF06733;PF06741;PF07525;PF07546;PF07645;PF07653;PF07679;PF07686;PF07710;PF08210;PF08246;PF08295;PF08563;PF08953;PF08954;PF09058;PF09289;PF09307;PF09379;PF09380;PF10401;PF10409;PF10524;PF10608;PF11934;PF11977;PF12047;PF12470;PF12548;PF12697;PF12701;PF12763;PF12796;PF12906;PF12924;PF12925;PF13086;PF13353;PF13405;PF13639;PF13716;PF13733;PF13854;PF13855;PF13905;PF14259;PF14324
Group	GO:0032879	regulation of localization	1	7.71	2.79e-12	3.67e-10	81|425|318|3527	PF00019;PF00020;PF00027;PF00040;PF00045;PF00059;PF00063;PF00076;PF00085;PF00086;PF00093;PF00097;PF00122;PF00130;PF00168;PF00169;PF00254;PF00258;PF00307;PF00349;PF00362;PF00373;PF00400;PF00413;PF00435;PF00452;PF00564;PF00610;PF00611;PF00618;PF00622;PF00630;PF00667;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00884;PF00928;PF00969;PF01030;PF01044;PF01217;PF01302;PF01391;PF01392;PF01403;PF01437;PF01471;PF01562;PF01833;PF02145;PF02185;PF02214;PF03727;PF04810;PF04811;PF05076;PF07546;PF07645;PF07651;PF07653;PF07679;PF07686;PF07690;PF07965;PF08246;PF08725;PF10409;PF12470;PF12548;PF12697;PF12796;PF13353;PF13405;PF13637;PF13716;PF13855;PF13903
Group	GO:0065008	regulation of biological quality	1	7.07	1.95e-11	2.24e-09	128|425|628|3527	PF00019;PF00024;PF00027;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00093;PF00094;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00240;PF00241;PF00246;PF00254;PF00270;PF00271;PF00282;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00530;PF00583;PF00610;PF00611;PF00618;PF00622;PF00630;PF00642;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00780;PF00870;PF00928;PF00999;PF01017;PF01044;PF01217;PF01302;PF01336;PF01391;PF01392;PF01401;PF01403;PF01433;PF01437;PF01477;PF01496;PF01553;PF01562;PF01565;PF01602;PF01699;PF01715;PF01814;PF01826;PF01841;PF02145;PF02148;PF02177;PF02181;PF02214;PF02218;PF02225;PF02259;PF02260;PF02463;PF02765;PF02865;PF03165;PF03727;PF04382;PF04389;PF04811;PF05076;PF06367;PF06371;PF06733;PF06741;PF06920;PF07645;PF07653;PF07679;PF07686;PF07690;PF07707;PF07710;PF07973;PF08246;PF08563;PF08736;PF08742;PF08953;PF09379;PF09380;PF10409;PF10608;PF11971;PF12424;PF12470;PF12710;PF12756;PF12763;PF12796;PF12924;PF12925;PF13246;PF13405;PF13637;PF13716;PF13855;PF13903;PF14259;PF14429
Group	GO:0051641	cellular localization	1	6.48	1.01e-09	8.50e-08	103|425|494|3527	PF00019;PF00027;PF00053;PF00063;PF00076;PF00085;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00350;PF00400;PF00432;PF00435;PF00452;PF00515;PF00567;PF00610;PF00611;PF00618;PF00622;PF00630;PF00638;PF00651;PF00675;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00870;PF00928;PF00989;PF00999;PF01017;PF01044;PF01217;PF01302;PF01391;PF01392;PF01403;PF01412;PF01428;PF01465;PF01602;PF02138;PF02145;PF02177;PF02181;PF02359;PF02865;PF02881;PF02985;PF03810;PF04695;PF04810;PF04811;PF04841;PF05076;PF05193;PF06480;PF07645;PF07651;PF07653;PF07679;PF07707;PF07710;PF08389;PF08506;PF08563;PF08700;PF08953;PF08954;PF09177;PF09324;PF10559;PF10608;PF11413;PF11957;PF11971;PF12455;PF12470;PF12756;PF12763;PF12783;PF12796;PF12924;PF12925;PF13246;PF13385;PF13405;PF13637;PF13850;PF13855
Group	GO:0033036	macromolecule localization	1	6.43	2.53e-09	1.94e-07	80|425|354|3527	PF00019;PF00052;PF00053;PF00057;PF00063;PF00076;PF00122;PF00130;PF00168;PF00169;PF00226;PF00240;PF00241;PF00270;PF00271;PF00307;PF00350;PF00373;PF00400;PF00432;PF00435;PF00501;PF00515;PF00564;PF00567;PF00611;PF00630;PF00638;PF00675;PF00683;PF00688;PF00778;PF00870;PF00928;PF00999;PF01017;PF01044;PF01217;PF01302;PF01391;PF01392;PF01428;PF01465;PF01477;PF01602;PF02145;PF02359;PF02865;PF02881;PF02985;PF03765;PF03810;PF04695;PF04810;PF04811;PF05076;PF05193;PF07645;PF07653;PF07679;PF07710;PF08389;PF08506;PF08563;PF09058;PF09379;PF09380;PF10409;PF10559;PF10608;PF11957;PF12470;PF12710;PF12763;PF12796;PF13246;PF13405;PF13637;PF13855;PF14259
Group	GO:0048518	positive regulation of biological process	1	6.16	3.32e-09	2.35e-07	127|425|667|3527	PF00019;PF00020;PF00024;PF00027;PF00040;PF00053;PF00057;PF00059;PF00063;PF00072;PF00076;PF00086;PF00093;PF00122;PF00130;PF00133;PF00168;PF00169;PF00179;PF00240;PF00241;PF00270;PF00271;PF00307;PF00349;PF00362;PF00373;PF00400;PF00435;PF00452;PF00515;PF00530;PF00564;PF00605;PF00611;PF00618;PF00630;PF00642;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00870;PF00884;PF00969;PF00989;PF01017;PF01030;PF01302;PF01335;PF01391;PF01392;PF01403;PF01426;PF01437;PF01476;PF01485;PF01562;PF01585;PF01699;PF01833;PF02177;PF02181;PF02182;PF02185;PF02198;PF02218;PF02259;PF02260;PF02434;PF02463;PF02518;PF02865;PF03165;PF03172;PF03727;PF04811;PF04868;PF05790;PF06367;PF06371;PF06733;PF07525;PF07534;PF07645;PF07653;PF07679;PF07686;PF07710;PF07965;PF08209;PF08210;PF08246;PF08313;PF08563;PF08725;PF08788;PF09307;PF09771;PF10358;PF10401;PF10409;PF10524;PF11413;PF11648;PF11717;PF11971;PF12548;PF12697;PF12756;PF12763;PF12796;PF12924;PF12925;PF13086;PF13353;PF13405;PF13637;PF13639;PF13716;PF13855;PF14259;PF14324
Group	GO:0051128	regulation of cellular component organization	1	6.34	4.31e-09	2.84e-07	76|425|333|3527	PF00019;PF00024;PF00059;PF00063;PF00072;PF00086;PF00130;PF00168;PF00169;PF00179;PF00226;PF00241;PF00254;PF00270;PF00271;PF00307;PF00373;PF00400;PF00435;PF00452;PF00515;PF00610;PF00611;PF00618;PF00622;PF00651;PF00688;PF00754;PF00757;PF00780;PF00870;PF01030;PF01044;PF01088;PF01302;PF01391;PF01392;PF01403;PF01437;PF01562;PF01833;PF02008;PF02145;PF02148;PF02181;PF02185;PF02259;PF02260;PF02463;PF02518;PF03165;PF04382;PF04811;PF06367;PF06371;PF06733;PF07645;PF07651;PF07653;PF07679;PF07686;PF07707;PF07710;PF08210;PF08563;PF08736;PF08953;PF08954;PF09379;PF09380;PF10409;PF12796;PF12895;PF12906;PF13637;PF13855
Group	GO:0007399	nervous system development	1	6.24	5.24e-09	3.22e-07	86|425|397|3527	PF00019;PF00024;PF00052;PF00053;PF00057;PF00063;PF00122;PF00130;PF00168;PF00169;PF00246;PF00254;PF00307;PF00373;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00564;PF00610;PF00611;PF00618;PF00630;PF00651;PF00688;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00870;PF00884;PF01017;PF01030;PF01044;PF01291;PF01391;PF01392;PF01403;PF01437;PF01562;PF01833;PF02145;PF02148;PF02177;PF02181;PF02263;PF02377;PF02671;PF02865;PF03165;PF06367;PF06371;PF06741;PF07525;PF07531;PF07645;PF07653;PF07679;PF07686;PF07710;PF07965;PF08295;PF08506;PF08563;PF08725;PF08736;PF08788;PF09379;PF09380;PF10409;PF10524;PF10608;PF12424;PF12548;PF12796;PF12924;PF12925;PF13385;PF13716;PF13855;PF13903;PF14324
Group	GO:0051239	regulation of multicellular organismal process	1	6.06	1.10e-08	6.31e-07	93|425|448|3527	PF00019;PF00020;PF00024;PF00027;PF00059;PF00063;PF00072;PF00076;PF00086;PF00093;PF00122;PF00130;PF00168;PF00169;PF00240;PF00254;PF00258;PF00271;PF00307;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00622;PF00630;PF00642;PF00651;PF00667;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00870;PF00884;PF00969;PF01017;PF01391;PF01392;PF01401;PF01403;PF01437;PF01562;PF01699;PF01753;PF01833;PF02177;PF02181;PF02198;PF02214;PF02377;PF02518;PF02865;PF03165;PF03226;PF04811;PF04818;PF06367;PF06371;PF06741;PF07525;PF07531;PF07645;PF07653;PF07679;PF07686;PF07710;PF08246;PF08563;PF09307;PF10401;PF10409;PF10524;PF10608;PF11648;PF12548;PF12763;PF12796;PF12924;PF12925;PF13353;PF13405;PF13716;PF13855
Group	GO:0050793	regulation of developmental process	1	6.03	1.47e-08	7.96e-07	86|425|405|3527	PF00019;PF00024;PF00057;PF00063;PF00072;PF00076;PF00086;PF00093;PF00130;PF00168;PF00169;PF00179;PF00241;PF00254;PF00270;PF00271;PF00307;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00622;PF00630;PF00642;PF00651;PF00688;PF00778;PF00780;PF00870;PF00884;PF01017;PF01391;PF01392;PF01403;PF01437;PF01562;PF01753;PF01833;PF02177;PF02181;PF02185;PF02198;PF02377;PF02463;PF02518;PF02865;PF03165;PF03226;PF04382;PF04811;PF04818;PF06367;PF06371;PF07525;PF07531;PF07645;PF07679;PF07686;PF07710;PF08246;PF08563;PF08736;PF08953;PF09379;PF09380;PF10409;PF10524;PF12548;PF12763;PF12796;PF12906;PF12924;PF12925;PF13405;PF13637;PF13716;PF13855;PF14259
Group	GO:0080090	regulation of primary metabolic process	1	5.57	5.05e-08	2.45e-06	150|425|861|3527	PF00019;PF00020;PF00024;PF00027;PF00057;PF00059;PF00063;PF00072;PF00076;PF00086;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00630;PF00642;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF00789;PF00870;PF00899;PF00989;PF01017;PF01030;PF01088;PF01302;PF01335;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01530;PF01585;PF01624;PF01751;PF01753;PF01833;PF02008;PF02145;PF02148;PF02177;PF02182;PF02198;PF02199;PF02218;PF02262;PF02377;PF02463;PF02671;PF02761;PF02762;PF02865;PF02985;PF03165;PF03167;PF03172;PF03489;PF03638;PF03727;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05076;PF05184;PF05773;PF06733;PF06920;PF07525;PF07528;PF07531;PF07645;PF07653;PF07679;PF07686;PF07710;PF07973;PF08209;PF08210;PF08295;PF08313;PF08563;PF08662;PF08711;PF08788;PF09379;PF09380;PF09757;PF09771;PF10401;PF10524;PF11413;PF11717;PF11934;PF11971;PF11977;PF12047;PF12470;PF12697;PF12701;PF12756;PF12763;PF12796;PF12895;PF12924;PF12925;PF13086;PF13405;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13905;PF14259;PF14324;PF14429
Group	GO:0000003	reproduction	1	5.69	7.61e-08	3.05e-06	85|425|412|3527	PF00019;PF00045;PF00053;PF00063;PF00072;PF00076;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00258;PF00270;PF00271;PF00307;PF00350;PF00385;PF00400;PF00413;PF00435;PF00452;PF00564;PF00567;PF00618;PF00622;PF00630;PF00651;PF00667;PF00688;PF00702;PF00754;PF00757;PF00780;PF00870;PF00989;PF00999;PF01017;PF01030;PF01082;PF01131;PF01335;PF01392;PF01401;PF01465;PF01471;PF01504;PF01553;PF01562;PF01624;PF01715;PF01751;PF01753;PF02177;PF02181;PF02199;PF02259;PF02260;PF02463;PF02518;PF02865;PF03165;PF03489;PF03712;PF04083;PF04408;PF05033;PF05184;PF07525;PF07653;PF07679;PF07686;PF08700;PF09335;PF10585;PF12478;PF12796;PF12872;PF12924;PF12925;PF13589;PF13855;PF14259
Group	GO:0006928	cellular component movement	1	5.66	1.43e-07	5.06e-06	66|425|296|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00057;PF00063;PF00072;PF00130;PF00168;PF00169;PF00226;PF00241;PF00282;PF00307;PF00362;PF00373;PF00400;PF00413;PF00435;PF00515;PF00530;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF00928;PF00989;PF01030;PF01217;PF01302;PF01403;PF01437;PF01471;PF01562;PF01602;PF01833;PF02148;PF02177;PF02181;PF02185;PF02214;PF03133;PF06367;PF06371;PF06480;PF06920;PF07645;PF07653;PF07679;PF07686;PF07965;PF08725;PF08953;PF08954;PF09379;PF10409;PF11413;PF11971;PF12924;PF12925;PF13405;PF13855;PF14429
Group	GO:0031323	regulation of cellular metabolic process	1	5.35	1.53e-07	5.20e-06	149|425|867|3527	PF00019;PF00020;PF00027;PF00057;PF00059;PF00063;PF00072;PF00076;PF00086;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00630;PF00642;PF00651;PF00688;PF00757;PF00778;PF00780;PF00789;PF00870;PF00899;PF00989;PF01017;PF01030;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01477;PF01530;PF01585;PF01624;PF01751;PF01753;PF01833;PF02008;PF02145;PF02148;PF02177;PF02182;PF02198;PF02218;PF02259;PF02260;PF02377;PF02463;PF02518;PF02671;PF02770;PF02771;PF02865;PF02985;PF03165;PF03167;PF03172;PF03638;PF03727;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05076;PF05773;PF06733;PF06920;PF07525;PF07528;PF07531;PF07645;PF07653;PF07679;PF07686;PF07710;PF07973;PF08209;PF08210;PF08295;PF08313;PF08563;PF08662;PF08711;PF08788;PF09379;PF09380;PF09757;PF09771;PF10401;PF10524;PF10608;PF11413;PF11717;PF11934;PF11971;PF11977;PF12047;PF12470;PF12697;PF12701;PF12756;PF12763;PF12796;PF12895;PF12924;PF12925;PF13086;PF13405;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13905;PF14259;PF14324;PF14429
Group	GO:0042221	response to chemical stimulus	1	5.30	2.92e-07	8.88e-06	113|425|615|3527	PF00019;PF00020;PF00027;PF00040;PF00045;PF00052;PF00053;PF00057;PF00059;PF00063;PF00072;PF00076;PF00085;PF00093;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00224;PF00226;PF00240;PF00258;PF00270;PF00271;PF00307;PF00349;PF00362;PF00373;PF00400;PF00413;PF00435;PF00452;PF00501;PF00515;PF00583;PF00605;PF00622;PF00630;PF00651;PF00667;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00870;PF00969;PF00989;PF00999;PF01017;PF01030;PF01082;PF01370;PF01391;PF01392;PF01403;PF01437;PF01471;PF01554;PF01833;PF01909;PF02145;PF02148;PF02177;PF02199;PF02218;PF02263;PF02463;PF02518;PF02760;PF02865;PF02881;PF02887;PF03165;PF03489;PF03712;PF03727;PF05184;PF06920;PF07525;PF07645;PF07653;PF07679;PF07686;PF07690;PF07710;PF07965;PF08246;PF08416;PF08563;PF08725;PF08736;PF08953;PF08954;PF10401;PF10409;PF10524;PF11413;PF12796;PF12924;PF12925;PF13405;PF13639;PF13716;PF13848;PF13855;PF14429
Group	GO:0060255	regulation of macromolecule metabolic process	1	5.21	2.99e-07	8.88e-06	148|425|868|3527	PF00019;PF00020;PF00024;PF00027;PF00057;PF00059;PF00072;PF00076;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00515;PF00530;PF00564;PF00567;PF00605;PF00610;PF00630;PF00642;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF00789;PF00870;PF00899;PF00989;PF01017;PF01030;PF01088;PF01302;PF01335;PF01336;PF01352;PF01391;PF01392;PF01403;PF01426;PF01437;PF01477;PF01530;PF01585;PF01624;PF01751;PF01753;PF01833;PF02008;PF02145;PF02148;PF02177;PF02182;PF02198;PF02218;PF02259;PF02262;PF02377;PF02463;PF02671;PF02761;PF02762;PF02865;PF02881;PF02985;PF03165;PF03167;PF03172;PF03638;PF03727;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05076;PF05773;PF06464;PF06733;PF07525;PF07528;PF07531;PF07645;PF07653;PF07679;PF07686;PF07710;PF07973;PF08209;PF08210;PF08246;PF08295;PF08313;PF08563;PF08662;PF08711;PF08788;PF09379;PF09380;PF09416;PF09757;PF09771;PF10401;PF10409;PF10524;PF11413;PF11717;PF11934;PF11977;PF12047;PF12470;PF12701;PF12756;PF12763;PF12796;PF12872;PF12895;PF12924;PF12925;PF12933;PF12934;PF13086;PF13405;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13905;PF14259;PF14324
Group	GO:0009605	response to external stimulus	1	5.19	9.87e-07	2.46e-05	69|425|330|3527	PF00019;PF00020;PF00027;PF00052;PF00053;PF00059;PF00063;PF00072;PF00076;PF00082;PF00122;PF00149;PF00271;PF00307;PF00362;PF00373;PF00400;PF00435;PF00501;PF00564;PF00618;PF00622;PF00630;PF00651;PF00688;PF00689;PF00690;PF00702;PF00754;PF00778;PF00780;PF00899;PF00969;PF01017;PF01391;PF01392;PF01403;PF01437;PF01504;PF01833;PF02145;PF02148;PF02177;PF02259;PF02260;PF02518;PF02824;PF02865;PF03165;PF05773;PF05922;PF06920;PF07645;PF07679;PF07686;PF07965;PF08246;PF08725;PF08736;PF08953;PF08954;PF10409;PF10524;PF12796;PF12924;PF12925;PF13637;PF13855;PF14429
Group	GO:0006950	response to stress	1	4.98	1.13e-06	2.74e-05	124|425|709|3527	PF00019;PF00020;PF00024;PF00027;PF00040;PF00045;PF00057;PF00059;PF00063;PF00072;PF00076;PF00082;PF00085;PF00093;PF00094;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00350;PF00362;PF00373;PF00400;PF00413;PF00435;PF00452;PF00501;PF00515;PF00530;PF00534;PF00564;PF00605;PF00618;PF00622;PF00651;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00780;PF00870;PF00899;PF00969;PF00989;PF00999;PF01017;PF01030;PF01033;PF01302;PF01336;PF01391;PF01471;PF01476;PF01477;PF01565;PF01624;PF01826;PF01833;PF01841;PF01909;PF02145;PF02177;PF02259;PF02260;PF02263;PF02359;PF02463;PF02518;PF02824;PF02865;PF02881;PF03167;PF04389;PF05773;PF05790;PF05922;PF06427;PF06733;PF06920;PF07534;PF07645;PF07653;PF07679;PF07686;PF07710;PF07965;PF08064;PF08150;PF08151;PF08165;PF08246;PF08563;PF08725;PF08742;PF10391;PF10401;PF10409;PF10482;PF11413;PF11648;PF11717;PF12697;PF12842;PF12924;PF12925;PF13086;PF13353;PF13405;PF13589;PF13639;PF13716;PF13848;PF13855;PF14324;PF14429
Group	GO:0007163	establishment or maintenance of cell polarity	1	5.44	2.01e-06	4.42e-05	27|425|88|3527	PF00052;PF00053;PF00057;PF00063;PF00130;PF00169;PF00307;PF00373;PF00400;PF00435;PF00564;PF00610;PF00651;PF00778;PF01302;PF02181;PF04811;PF06367;PF06371;PF07653;PF07679;PF08736;PF09379;PF09380;PF10608;PF13855;PF14259
Group	GO:0044260	cellular macromolecule metabolic process	1	4.67	2.34e-06	4.89e-05	216|425|1425|3527	PF00019;PF00027;PF00057;PF00063;PF00076;PF00082;PF00085;PF00094;PF00097;PF00122;PF00130;PF00133;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00246;PF00254;PF00258;PF00266;PF00270;PF00271;PF00373;PF00385;PF00400;PF00415;PF00432;PF00452;PF00515;PF00530;PF00534;PF00535;PF00557;PF00564;PF00567;PF00583;PF00605;PF00611;PF00622;PF00630;PF00642;PF00651;PF00667;PF00675;PF00688;PF00702;PF00749;PF00754;PF00757;PF00780;PF00789;PF00870;PF00884;PF00899;PF00989;PF01017;PF01030;PF01055;PF01088;PF01131;PF01189;PF01302;PF01336;PF01370;PF01426;PF01480;PF01485;PF01530;PF01562;PF01565;PF01585;PF01624;PF01663;PF01715;PF01751;PF01753;PF01805;PF01814;PF01841;PF01909;PF02008;PF02148;PF02177;PF02182;PF02185;PF02198;PF02214;PF02225;PF02259;PF02260;PF02359;PF02434;PF02463;PF02518;PF02671;PF02765;PF02824;PF02865;PF02881;PF02969;PF03133;PF03155;PF03165;PF03167;PF03256;PF03485;PF03909;PF04046;PF04137;PF04389;PF04408;PF04557;PF04558;PF04561;PF04563;PF04721;PF04756;PF04762;PF04810;PF04811;PF04818;PF04868;PF04926;PF05020;PF05021;PF05024;PF05033;PF05193;PF05207;PF05383;PF05773;PF05922;PF06058;PF06427;PF06464;PF06544;PF06733;PF07034;PF07528;PF07531;PF07645;PF07653;PF07679;PF07707;PF07710;PF07973;PF08032;PF08064;PF08075;PF08210;PF08288;PF08295;PF08563;PF08567;PF08612;PF08644;PF08662;PF08711;PF08736;PF08926;PF09247;PF09379;PF09380;PF09409;PF09416;PF09739;PF09757;PF10250;PF10391;PF10401;PF10409;PF10436;PF10482;PF10524;PF10585;PF11413;PF11701;PF11717;PF11816;PF12047;PF12148;PF12548;PF12619;PF12697;PF12796;PF12842;PF12872;PF12894;PF12895;PF12906;PF12924;PF12925;PF12933;PF12934;PF13086;PF13191;PF13344;PF13353;PF13519;PF13589;PF13599;PF13637;PF13639;PF13691;PF13733;PF13802;PF13831;PF13832;PF13848;PF13855;PF13891;PF14259;PF14324;PF14443
Group	GO:0051234	establishment of localization	1	4.78	2.55e-06	5.08e-05	133|425|785|3527	PF00019;PF00027;PF00040;PF00053;PF00057;PF00059;PF00063;PF00076;PF00085;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00226;PF00241;PF00254;PF00270;PF00271;PF00307;PF00349;PF00350;PF00400;PF00432;PF00435;PF00452;PF00501;PF00515;PF00610;PF00611;PF00618;PF00622;PF00630;PF00638;PF00651;PF00675;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00870;PF00928;PF00989;PF00999;PF01017;PF01033;PF01145;PF01217;PF01302;PF01391;PF01412;PF01426;PF01428;PF01465;PF01477;PF01496;PF01504;PF01553;PF01554;PF01562;PF01602;PF01699;PF01833;PF02138;PF02145;PF02177;PF02214;PF02225;PF02359;PF02770;PF02865;PF02881;PF02985;PF03489;PF03727;PF03765;PF03810;PF04389;PF04695;PF04756;PF04810;PF04811;PF04841;PF05184;PF05193;PF06480;PF07546;PF07645;PF07651;PF07653;PF07679;PF07686;PF07690;PF07707;PF07710;PF08150;PF08151;PF08246;PF08389;PF08506;PF08563;PF08700;PF08911;PF08953;PF08954;PF09177;PF09324;PF10366;PF10559;PF11413;PF11601;PF11957;PF11971;PF12424;PF12455;PF12710;PF12763;PF12783;PF12796;PF12924;PF12925;PF13246;PF13385;PF13405;PF13519;PF13637;PF13850;PF13855;PF14259
Group	GO:0002376	immune system process	1	4.90	3.32e-06	6.31e-05	68|425|334|3527	PF00019;PF00020;PF00057;PF00059;PF00063;PF00085;PF00130;PF00153;PF00168;PF00169;PF00179;PF00240;PF00254;PF00270;PF00271;PF00350;PF00362;PF00452;PF00605;PF00651;PF00688;PF00780;PF00870;PF00969;PF01017;PF01033;PF01335;PF01391;PF01392;PF01433;PF01476;PF01562;PF01624;PF01909;PF02138;PF02218;PF02263;PF02463;PF02865;PF02881;PF03172;PF04810;PF04811;PF05790;PF07534;PF07645;PF07653;PF07679;PF07686;PF07710;PF07965;PF08246;PF08563;PF08725;PF08916;PF08953;PF08954;PF10401;PF10409;PF11648;PF11971;PF12697;PF12796;PF13353;PF13637;PF13639;PF13855;PF14324
Group	GO:0032990	cell part morphogenesis	1	4.96	4.25e-06	7.66e-05	48|425|210|3527	PF00024;PF00052;PF00053;PF00063;PF00130;PF00168;PF00169;PF00271;PF00307;PF00400;PF00415;PF00435;PF00515;PF00611;PF00630;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01044;PF01391;PF01403;PF01437;PF01833;PF02148;PF02177;PF02263;PF02377;PF02671;PF03133;PF03165;PF06741;PF07645;PF07653;PF07679;PF08295;PF08736;PF10162;PF10524;PF10608;PF12796;PF12924;PF12925;PF13716;PF13855
Group	GO:0007154	cell communication	1	4.66	4.81e-06	8.20e-05	119|425|691|3527	PF00019;PF00020;PF00027;PF00057;PF00059;PF00063;PF00072;PF00076;PF00082;PF00085;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00282;PF00307;PF00349;PF00362;PF00373;PF00400;PF00435;PF00452;PF00564;PF00605;PF00610;PF00611;PF00618;PF00622;PF00630;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00870;PF00884;PF00899;PF00928;PF00969;PF00989;PF01017;PF01030;PF01044;PF01217;PF01291;PF01302;PF01370;PF01391;PF01392;PF01403;PF01412;PF01437;PF01465;PF01504;PF01562;PF01602;PF01833;PF02140;PF02145;PF02177;PF02185;PF02214;PF02259;PF02260;PF02262;PF02359;PF02377;PF02463;PF02518;PF02759;PF02761;PF02762;PF02824;PF02865;PF03165;PF03727;PF03920;PF04739;PF05773;PF05790;PF05922;PF07525;PF07645;PF07653;PF07679;PF07686;PF07690;PF07707;PF07710;PF07965;PF08246;PF08506;PF08563;PF08725;PF08916;PF10250;PF10401;PF10409;PF10427;PF10608;PF11971;PF12548;PF12763;PF12796;PF12924;PF12925;PF13639;PF13716;PF13855
Group	GO:0023052	signaling	1	4.66	4.94e-06	8.27e-05	113|425|648|3527	PF00019;PF00020;PF00027;PF00057;PF00059;PF00063;PF00072;PF00076;PF00085;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00282;PF00307;PF00349;PF00362;PF00373;PF00400;PF00435;PF00452;PF00564;PF00605;PF00610;PF00611;PF00618;PF00622;PF00630;PF00638;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00870;PF00884;PF00928;PF00969;PF00989;PF01017;PF01030;PF01044;PF01217;PF01291;PF01302;PF01370;PF01391;PF01392;PF01403;PF01412;PF01437;PF01465;PF01504;PF01562;PF01602;PF01833;PF02140;PF02145;PF02177;PF02185;PF02214;PF02259;PF02260;PF02262;PF02359;PF02377;PF02463;PF02518;PF02759;PF02761;PF02762;PF02865;PF03165;PF03727;PF04739;PF05790;PF07525;PF07645;PF07653;PF07679;PF07686;PF07690;PF07707;PF07710;PF07965;PF08246;PF08506;PF08563;PF08725;PF08916;PF10250;PF10401;PF10409;PF10608;PF11971;PF12548;PF12763;PF12796;PF12924;PF12925;PF13639;PF13716;PF13855
Group	GO:0065009	regulation of molecular function	1	4.63	8.52e-06	1.35e-04	76|425|396|3527	PF00019;PF00020;PF00027;PF00057;PF00063;PF00076;PF00085;PF00086;PF00097;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00258;PF00307;PF00373;PF00400;PF00415;PF00452;PF00564;PF00610;PF00611;PF00618;PF00622;PF00630;PF00667;PF00688;PF00757;PF00778;PF00780;PF00870;PF00899;PF01017;PF01302;PF01335;PF01391;PF01392;PF01403;PF01412;PF01437;PF01585;PF01909;PF02145;PF02148;PF02177;PF02377;PF02434;PF02865;PF03165;PF04382;PF04868;PF06239;PF06920;PF07525;PF07645;PF07653;PF07679;PF08246;PF08736;PF09324;PF09379;PF09380;PF10608;PF11934;PF11971;PF12796;PF12924;PF12925;PF13405;PF13716;PF13855;PF13903;PF14429
Group	GO:0051171	regulation of nitrogen compound metabolic process	1	4.41	1.40e-05	2.05e-04	111|425|647|3527	PF00019;PF00020;PF00027;PF00063;PF00072;PF00076;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00270;PF00271;PF00307;PF00385;PF00400;PF00435;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00630;PF00642;PF00651;PF00688;PF00757;PF00780;PF00870;PF00899;PF00989;PF01017;PF01030;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01530;PF01585;PF01624;PF01751;PF01753;PF01833;PF02008;PF02145;PF02177;PF02182;PF02198;PF02463;PF02518;PF02671;PF02865;PF03165;PF03167;PF03172;PF03638;PF03920;PF04408;PF04762;PF04818;PF05033;PF05076;PF06733;PF06920;PF07528;PF07531;PF07645;PF07653;PF07679;PF07710;PF08209;PF08210;PF08295;PF08313;PF08563;PF08711;PF08788;PF09757;PF10401;PF10524;PF11413;PF11717;PF11934;PF11971;PF12047;PF12470;PF12756;PF12796;PF12895;PF12924;PF12925;PF13086;PF13405;PF13716;PF13831;PF13832;PF13854;PF13855;PF14259;PF14324;PF14429
Group	GO:0030030	cell projection organization	1	4.54	1.85e-05	2.58e-04	52|425|246|3527	PF00019;PF00024;PF00052;PF00053;PF00063;PF00130;PF00168;PF00169;PF00307;PF00373;PF00400;PF00415;PF00435;PF00515;PF00610;PF00611;PF00618;PF00630;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01044;PF01391;PF01403;PF01437;PF01833;PF02148;PF02177;PF02263;PF02377;PF02671;PF03133;PF03165;PF06741;PF07645;PF07653;PF07679;PF08295;PF08736;PF08953;PF10162;PF10524;PF10608;PF12796;PF12924;PF12925;PF13716;PF13855
Group	GO:0051674	localization of cell	1	4.28	5.03e-05	5.94e-04	48|425|229|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00057;PF00063;PF00072;PF00130;PF00226;PF00241;PF00282;PF00307;PF00362;PF00373;PF00413;PF00435;PF00515;PF00530;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF01030;PF01403;PF01437;PF01471;PF01562;PF01833;PF02148;PF02185;PF02214;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07686;PF07965;PF08725;PF08953;PF10409;PF11971;PF13855;PF14429
Group	GO:0009056	catabolic process	1	4.09	5.57e-05	6.33e-04	94|425|543|3527	PF00019;PF00063;PF00082;PF00085;PF00097;PF00122;PF00149;PF00153;PF00168;PF00179;PF00205;PF00224;PF00226;PF00240;PF00258;PF00266;PF00270;PF00271;PF00282;PF00289;PF00349;PF00350;PF00400;PF00452;PF00456;PF00501;PF00515;PF00557;PF00564;PF00583;PF00622;PF00642;PF00667;PF00688;PF00689;PF00690;PF00702;PF00703;PF00723;PF00789;PF00899;PF00970;PF01055;PF01180;PF01370;PF01391;PF01433;PF01477;PF01485;PF01546;PF01565;PF01597;PF01624;PF01814;PF01841;PF01909;PF02148;PF02214;PF02260;PF02263;PF02359;PF02463;PF02518;PF02746;PF02770;PF02771;PF02837;PF02881;PF02887;PF03167;PF03256;PF03727;PF04389;PF04721;PF05020;PF05021;PF05922;PF06058;PF06480;PF07707;PF08210;PF08246;PF09409;PF09416;PF10409;PF12697;PF12842;PF12895;PF13086;PF13519;PF13589;PF13639;PF13802;PF14259
Group	GO:0000902	cell morphogenesis	1	4.13	7.70e-05	8.14e-04	53|425|265|3527	PF00019;PF00024;PF00052;PF00053;PF00063;PF00130;PF00168;PF00169;PF00307;PF00373;PF00400;PF00415;PF00435;PF00515;PF00530;PF00611;PF00630;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF00999;PF01030;PF01044;PF01391;PF01392;PF01403;PF01437;PF01833;PF02148;PF02177;PF02263;PF02377;PF02671;PF03133;PF03165;PF06741;PF06920;PF07645;PF07653;PF07679;PF08295;PF08736;PF10162;PF10524;PF10608;PF12796;PF12924;PF12925;PF13716;PF13855
Group	GO:0040011	locomotion	1	3.98	1.11e-04	1.08e-03	64|425|342|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00057;PF00063;PF00072;PF00130;PF00169;PF00226;PF00241;PF00282;PF00307;PF00362;PF00373;PF00413;PF00435;PF00515;PF00530;PF00611;PF00618;PF00630;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01391;PF01392;PF01403;PF01437;PF01471;PF01562;PF01833;PF02145;PF02148;PF02177;PF02185;PF02214;PF02518;PF03165;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07686;PF07965;PF08725;PF08736;PF08953;PF08954;PF10409;PF10524;PF11971;PF12424;PF12924;PF12925;PF13855;PF14429
Group	GO:0051716	cellular response to stimulus	1	3.77	1.45e-04	1.30e-03	134|425|853|3527	PF00019;PF00020;PF00027;PF00040;PF00057;PF00059;PF00063;PF00072;PF00076;PF00082;PF00085;PF00093;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00362;PF00373;PF00400;PF00435;PF00452;PF00501;PF00564;PF00583;PF00605;PF00610;PF00611;PF00618;PF00622;PF00630;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00870;PF00884;PF00899;PF00969;PF00989;PF00999;PF01017;PF01030;PF01291;PF01302;PF01336;PF01370;PF01391;PF01392;PF01403;PF01412;PF01437;PF01562;PF01624;PF01833;PF01909;PF02140;PF02145;PF02177;PF02185;PF02199;PF02259;PF02260;PF02262;PF02263;PF02359;PF02377;PF02463;PF02518;PF02759;PF02760;PF02761;PF02762;PF02824;PF02865;PF02881;PF03165;PF03167;PF03489;PF04739;PF05184;PF05773;PF05790;PF05922;PF06733;PF07525;PF07645;PF07653;PF07679;PF07686;PF07707;PF07710;PF07965;PF08064;PF08246;PF08506;PF08563;PF08725;PF08916;PF08953;PF10250;PF10391;PF10401;PF10409;PF10482;PF11413;PF11717;PF11971;PF12548;PF12763;PF12796;PF12842;PF12924;PF12925;PF13086;PF13405;PF13589;PF13639;PF13716;PF13848;PF13855;PF14324
Group	GO:0009790	embryo development	1	3.71	3.06e-04	2.21e-03	56|425|299|3527	PF00019;PF00052;PF00053;PF00057;PF00063;PF00076;PF00093;PF00122;PF00130;PF00133;PF00168;PF00169;PF00307;PF00373;PF00400;PF00435;PF00452;PF00564;PF00567;PF00583;PF00610;PF00622;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00870;PF00884;PF00989;PF01030;PF01391;PF01392;PF01403;PF02008;PF02145;PF02185;PF02377;PF03165;PF05033;PF07525;PF07645;PF07653;PF07679;PF07686;PF07710;PF08563;PF08736;PF09379;PF09380;PF10250;PF12548;PF12796;PF12872
Group	GO:0009889	regulation of biosynthetic process	1	3.10	1.57e-03	7.35e-03	101|425|646|3527	PF00019;PF00020;PF00059;PF00072;PF00076;PF00097;PF00130;PF00168;PF00169;PF00179;PF00270;PF00271;PF00307;PF00349;PF00385;PF00400;PF00435;PF00515;PF00530;PF00564;PF00605;PF00630;PF00642;PF00651;PF00688;PF00757;PF00870;PF00899;PF00989;PF01017;PF01030;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01426;PF01530;PF01585;PF01753;PF01833;PF02008;PF02177;PF02182;PF02198;PF02259;PF02463;PF02518;PF02671;PF02865;PF03165;PF03167;PF03172;PF03638;PF03727;PF03920;PF04762;PF04818;PF05033;PF05076;PF05773;PF07528;PF07531;PF07645;PF07679;PF07686;PF07710;PF07973;PF08209;PF08210;PF08295;PF08313;PF08563;PF08662;PF08711;PF08788;PF09757;PF09771;PF10401;PF10524;PF11413;PF11717;PF11934;PF12047;PF12470;PF12701;PF12756;PF12796;PF12895;PF12924;PF12925;PF13086;PF13405;PF13716;PF13831;PF13832;PF13854;PF13855;PF14259;PF14324
Group	GO:0042060	wound healing	2	7.67	1.49e-10	1.53e-08	33|425|85|3527	PF00024;PF00027;PF00063;PF00093;PF00094;PF00122;PF00130;PF00168;PF00169;PF00307;PF00373;PF00435;PF00618;PF00622;PF00689;PF00690;PF00702;PF00754;PF00757;PF01030;PF01826;PF01841;PF04389;PF06920;PF07653;PF07679;PF07686;PF08150;PF08151;PF08165;PF08742;PF13716;PF14429
Group	GO:0009968	negative regulation of signal transduction	2	7.04	6.15e-10	5.66e-08	48|425|162|3527	PF00019;PF00057;PF00072;PF00093;PF00130;PF00168;PF00169;PF00373;PF00400;PF00651;PF00683;PF00688;PF00778;PF00870;PF00884;PF01017;PF01302;PF01391;PF01392;PF01585;PF01833;PF02145;PF02214;PF02262;PF02761;PF02762;PF02865;PF03165;PF03226;PF03920;PF05076;PF07525;PF07645;PF07679;PF08563;PF09289;PF09379;PF09380;PF10409;PF12470;PF12548;PF12763;PF12796;PF13405;PF13639;PF13855;PF13905;PF14324
Group	GO:0018193	peptidyl-amino acid modification	2	6.24	3.03e-08	1.55e-06	43|425|153|3527	PF00085;PF00130;PF00168;PF00169;PF00240;PF00246;PF00254;PF00258;PF00373;PF00400;PF00535;PF00557;PF00583;PF00611;PF00667;PF00754;PF00757;PF00899;PF01030;PF01302;PF01530;PF01753;PF02259;PF02260;PF02518;PF02865;PF03133;PF04389;PF04756;PF04810;PF04811;PF05033;PF05207;PF07645;PF07679;PF09247;PF11717;PF12796;PF13733;PF13831;PF13832;PF13855;PF13891
Group	GO:2000145	regulation of cell motility	2	6.26	5.67e-08	2.61e-06	33|425|104|3527	PF00019;PF00045;PF00086;PF00093;PF00130;PF00168;PF00362;PF00373;PF00413;PF00688;PF00757;PF00884;PF01030;PF01044;PF01391;PF01392;PF01403;PF01437;PF01471;PF01562;PF01833;PF02185;PF07546;PF07645;PF07653;PF07679;PF07965;PF08246;PF08725;PF10409;PF12548;PF13716;PF13855
Group	GO:0006508	proteolysis	2	5.99	6.85e-08	3.00e-06	47|425|179|3527	PF00040;PF00045;PF00057;PF00063;PF00076;PF00082;PF00085;PF00097;PF00168;PF00179;PF00226;PF00240;PF00246;PF00400;PF00413;PF00452;PF00515;PF00530;PF00622;PF00675;PF00789;PF01433;PF01471;PF01485;PF01546;PF01562;PF01814;PF02148;PF02214;PF02225;PF02359;PF03256;PF04389;PF05020;PF05021;PF05193;PF05922;PF07687;PF07707;PF08246;PF08367;PF12895;PF13405;PF13519;PF13589;PF13620;PF13639
Group	GO:0031329	regulation of cellular catabolic process	2	6.16	7.23e-08	3.03e-06	35|425|115|3527	PF00027;PF00063;PF00076;PF00130;PF00168;PF00169;PF00226;PF00240;PF00271;PF00307;PF00373;PF00400;PF00515;PF00610;PF00611;PF00618;PF00642;PF00778;PF00780;PF00789;PF01403;PF01412;PF01437;PF02145;PF02148;PF02259;PF02260;PF06920;PF07653;PF11971;PF11977;PF12697;PF13716;PF13855;PF14429
Group	GO:0030198	extracellular matrix organization	2	6.41	8.16e-08	3.13e-06	24|425|63|3527	PF00019;PF00045;PF00052;PF00053;PF00057;PF00063;PF00086;PF00093;PF00413;PF00530;PF00688;PF01391;PF01392;PF01471;PF01562;PF02177;PF04810;PF04811;PF07679;PF12924;PF12925;PF13716;PF13733;PF13855
Group	GO:0051235	maintenance of location	2	6.67	1.00e-07	3.70e-06	17|425|35|3527	PF00122;PF00241;PF00307;PF00400;PF00435;PF00630;PF00683;PF00689;PF00690;PF00702;PF01044;PF05076;PF07645;PF11971;PF12470;PF12756;PF12796
Group	GO:0007346	regulation of mitotic cell cycle	2	5.90	2.64e-07	8.69e-06	31|425|100|3527	PF00019;PF00076;PF00130;PF00168;PF00270;PF00271;PF00452;PF00515;PF00688;PF00870;PF01017;PF01426;PF02148;PF02177;PF02865;PF06733;PF07653;PF07679;PF07686;PF07710;PF08563;PF09058;PF10608;PF11934;PF12796;PF12895;PF12924;PF12925;PF13086;PF13639;PF14324
Group	GO:0007292	female gamete generation	2	6.00	2.91e-07	8.88e-06	26|425|76|3527	PF00063;PF00076;PF00130;PF00168;PF00258;PF00270;PF00271;PF00307;PF00350;PF00385;PF00435;PF00564;PF00567;PF00618;PF00622;PF00630;PF00651;PF00667;PF01562;PF03165;PF07525;PF07653;PF07679;PF07686;PF12872;PF14259
Group	GO:0035556	intracellular signal transduction	2	5.54	4.64e-07	1.33e-05	46|425|184|3527	PF00027;PF00063;PF00072;PF00122;PF00130;PF00149;PF00168;PF00169;PF00240;PF00270;PF00400;PF00435;PF00452;PF00564;PF00610;PF00611;PF00618;PF00651;PF00689;PF00690;PF00702;PF00780;PF00870;PF01017;PF01302;PF01412;PF02145;PF02185;PF02259;PF02260;PF02463;PF02759;PF02865;PF07525;PF07645;PF07653;PF07679;PF07710;PF08246;PF08563;PF08916;PF10409;PF11971;PF12763;PF13716;PF13855
Group	GO:0048610	cellular process involved in reproduction	2	5.46	5.86e-07	1.64e-05	48|425|197|3527	PF00019;PF00063;PF00076;PF00130;PF00149;PF00168;PF00179;PF00240;PF00270;PF00271;PF00307;PF00350;PF00385;PF00435;PF00452;PF00564;PF00567;PF00622;PF00630;PF00651;PF00688;PF00870;PF00999;PF01504;PF01562;PF01624;PF01715;PF01751;PF01753;PF02199;PF02259;PF02260;PF02463;PF02518;PF02865;PF03165;PF03489;PF04408;PF05033;PF05184;PF07525;PF07653;PF07679;PF07686;PF12796;PF12872;PF13589;PF14259
Group	GO:0001932	regulation of protein phosphorylation	2	5.48	6.73e-07	1.82e-05	43|425|169|3527	PF00019;PF00020;PF00027;PF00057;PF00097;PF00169;PF00226;PF00240;PF00373;PF00400;PF00415;PF00452;PF00564;PF00610;PF00688;PF00757;PF00778;PF00780;PF01030;PF01302;PF01391;PF01392;PF01403;PF01437;PF01585;PF02145;PF02177;PF02218;PF02377;PF04868;PF07525;PF07645;PF07653;PF07679;PF09379;PF09380;PF11934;PF12796;PF12924;PF12925;PF13405;PF13716;PF13855
Group	GO:0045786	negative regulation of cell cycle	2	5.90	7.36e-07	1.94e-05	21|425|56|3527	PF00019;PF00270;PF00271;PF00350;PF00605;PF00688;PF00870;PF01477;PF02148;PF02260;PF06733;PF07645;PF07653;PF07679;PF07710;PF08563;PF09058;PF10409;PF10608;PF11934;PF13086
Group	GO:0008360	regulation of cell shape	2	5.81	8.74e-07	2.24e-05	22|425|61|3527	PF00024;PF00063;PF00130;PF00169;PF00373;PF00611;PF00618;PF00780;PF01403;PF01437;PF02181;PF04382;PF04811;PF06367;PF06371;PF07679;PF07686;PF08736;PF08953;PF09379;PF09380;PF10409
Group	GO:0034330	cell junction organization	2	5.65	1.34e-06	3.18e-05	23|425|67|3527	PF00019;PF00052;PF00053;PF00130;PF00168;PF00169;PF00307;PF00362;PF00373;PF00435;PF00564;PF00688;PF01044;PF01391;PF07645;PF07653;PF07679;PF07686;PF07965;PF08725;PF09379;PF09380;PF13903
Group	GO:0060541	respiratory system development	2	5.53	1.56e-06	3.50e-05	26|425|82|3527	PF00019;PF00045;PF00057;PF00059;PF00130;PF00240;PF00307;PF00413;PF00435;PF00564;PF00688;PF01391;PF01471;PF02181;PF03165;PF04811;PF06367;PF06371;PF07645;PF07653;PF07679;PF08246;PF10409;PF10524;PF13855;PF13903
Group	GO:0050878	regulation of body fluid levels	2	5.53	1.56e-06	3.50e-05	26|425|82|3527	PF00024;PF00027;PF00059;PF00093;PF00094;PF00122;PF00130;PF00169;PF00307;PF00373;PF00618;PF00689;PF00690;PF00702;PF00754;PF01017;PF01553;PF01826;PF01841;PF02865;PF06920;PF07679;PF07686;PF08742;PF12424;PF14429
Group	GO:0050817	coagulation	2	5.54	2.24e-06	4.79e-05	22|425|64|3527	PF00024;PF00027;PF00059;PF00093;PF00094;PF00122;PF00130;PF00169;PF00307;PF00373;PF00618;PF00689;PF00690;PF00702;PF00754;PF01826;PF01841;PF06920;PF07679;PF07686;PF08742;PF14429
Group	GO:0007552	metamorphosis	2	5.44	2.53e-06	5.08e-05	24|425|74|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08736;PF09379;PF10409;PF12796;PF13855;PF14259
Group	GO:0007444	imaginal disc development	2	5.41	2.59e-06	5.08e-05	25|425|79|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07653;PF07679;PF07686;PF09379;PF12796;PF13637;PF13855;PF14259;PF14324
Group	GO:0032880	regulation of protein localization	2	5.34	3.36e-06	6.31e-05	25|425|80|3527	PF00019;PF00020;PF00059;PF00085;PF00097;PF00307;PF00564;PF00622;PF00630;PF00688;PF00757;PF00778;PF00969;PF01030;PF01302;PF01391;PF01392;PF05076;PF07686;PF12470;PF12796;PF13353;PF13405;PF13716;PF13855
Group	GO:0002165	instar larval or pupal development	2	5.26	4.32e-06	7.66e-05	25|425|81|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08736;PF09379;PF09380;PF10409;PF12796;PF13855;PF14259
Group	GO:0006461	protein complex assembly	2	5.01	4.17e-06	7.66e-05	43|425|180|3527	PF00019;PF00063;PF00093;PF00094;PF00130;PF00168;PF00169;PF00179;PF00289;PF00350;PF00400;PF00452;PF00515;PF00564;PF00611;PF00622;PF00688;PF00757;PF00778;PF00969;PF00999;PF01030;PF01302;PF01391;PF01826;PF02148;PF02181;PF02214;PF02263;PF02771;PF02881;PF03165;PF04695;PF06309;PF06346;PF06367;PF06371;PF07645;PF07651;PF07679;PF08742;PF12763;PF13405
Group	GO:0060341	regulation of cellular localization	2	5.04	4.72e-06	8.19e-05	37|425|146|3527	PF00019;PF00020;PF00027;PF00059;PF00063;PF00076;PF00085;PF00097;PF00168;PF00169;PF00307;PF00349;PF00610;PF00618;PF00622;PF00630;PF00688;PF00757;PF00778;PF00969;PF01030;PF01302;PF01391;PF01392;PF01833;PF02214;PF03727;PF04810;PF04811;PF05076;PF07686;PF12470;PF12796;PF13353;PF13405;PF13716;PF13855
Group	GO:0009886	post-embryonic morphogenesis	2	5.10	6.83e-06	1.12e-04	26|425|88|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00452;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08736;PF09379;PF09380;PF10409;PF12796;PF13855;PF14259
Group	GO:0030155	regulation of cell adhesion	2	5.05	8.93e-06	1.37e-04	25|425|84|3527	PF00019;PF00063;PF00086;PF00093;PF00130;PF00149;PF00168;PF00169;PF00373;PF00651;PF00688;PF00754;PF01017;PF01391;PF01392;PF01562;PF02865;PF04811;PF06480;PF07645;PF07653;PF07679;PF10409;PF11971;PF13716
Group	GO:0016477	cell migration	2	4.80	8.90e-06	1.37e-04	43|425|185|3527	PF00019;PF00045;PF00052;PF00053;PF00057;PF00063;PF00130;PF00282;PF00307;PF00362;PF00413;PF00435;PF00515;PF00530;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF01030;PF01403;PF01437;PF01471;PF01562;PF01833;PF02148;PF02185;PF02214;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07686;PF07965;PF08725;PF08953;PF10409;PF11971;PF13855;PF14429
Group	GO:0051056	regulation of small GTPase mediated signal transduction	2	5.11	9.16e-06	1.38e-04	22|425|69|3527	PF00063;PF00130;PF00168;PF00169;PF00610;PF00611;PF00618;PF00651;PF00780;PF01403;PF01412;PF01437;PF01833;PF02145;PF02214;PF06920;PF07653;PF07679;PF12796;PF13716;PF13855;PF14429
Group	GO:0051051	negative regulation of transport	2	5.11	1.11e-05	1.65e-04	20|425|60|3527	PF00019;PF00130;PF00168;PF00258;PF00307;PF00400;PF00611;PF00622;PF00630;PF00667;PF00688;PF01302;PF01391;PF01833;PF05076;PF12470;PF12796;PF13353;PF13405;PF13716
Group	GO:0010564	regulation of cell cycle process	2	4.79	1.42e-05	2.05e-04	32|425|124|3527	PF00019;PF00076;PF00130;PF00149;PF00168;PF00240;PF00270;PF00271;PF00400;PF00452;PF00515;PF00688;PF00870;PF01336;PF01426;PF02148;PF02185;PF02259;PF02260;PF02463;PF06733;PF07679;PF07686;PF07710;PF08064;PF08563;PF11934;PF12796;PF12895;PF13086;PF13639;PF14324
Group	GO:0051130	positive regulation of cellular component organization	2	4.73	2.13e-05	2.93e-04	28|425|104|3527	PF00019;PF00059;PF00168;PF00241;PF00400;PF00452;PF00515;PF00611;PF00688;PF00870;PF01302;PF01391;PF01403;PF01437;PF02181;PF02185;PF02463;PF03165;PF06367;PF06371;PF07653;PF07679;PF07686;PF07710;PF08563;PF12796;PF13637;PF13855
Group	GO:0035239	tube morphogenesis	2	4.68	2.35e-05	3.18e-04	29|425|110|3527	PF00019;PF00045;PF00130;PF00168;PF00307;PF00400;PF00413;PF00435;PF00564;PF00651;PF00688;PF00754;PF00870;PF00989;PF01391;PF01392;PF01403;PF01437;PF01471;PF02145;PF03165;PF04811;PF05033;PF07653;PF07679;PF07686;PF07707;PF08246;PF13855
Group	GO:0006909	phagocytosis	2	4.90	2.84e-05	3.74e-04	17|425|49|3527	PF00053;PF00057;PF00059;PF00130;PF00400;PF01033;PF01217;PF01391;PF01426;PF01562;PF07546;PF07645;PF07679;PF07686;PF08953;PF08954;PF11971
Group	GO:0007009	plasma membrane organization	2	4.97	3.39e-05	4.39e-04	14|425|36|3527	PF00063;PF00168;PF00169;PF00307;PF00435;PF00611;PF00622;PF01391;PF08150;PF08151;PF08165;PF12796;PF13405;PF13637
Group	GO:0034762	regulation of transmembrane transport	2	4.64	3.81e-05	4.88e-04	23|425|80|3527	PF00019;PF00085;PF00168;PF00254;PF00307;PF00622;PF00630;PF00688;PF00757;PF00778;PF01030;PF01302;PF01391;PF01392;PF05076;PF07653;PF12470;PF12796;PF13405;PF13637;PF13716;PF13855;PF13903
Group	GO:0021700	developmental maturation	2	4.66	4.14e-05	5.09e-04	21|425|70|3527	PF00019;PF00076;PF00130;PF00169;PF00435;PF00564;PF00567;PF00622;PF00651;PF00688;PF01833;PF02177;PF07525;PF07679;PF10608;PF12796;PF12872;PF12924;PF12925;PF13855;PF14259
Group	GO:0030163	protein catabolic process	2	4.52	4.07e-05	5.09e-04	29|425|113|3527	PF00082;PF00085;PF00097;PF00168;PF00179;PF00226;PF00240;PF00400;PF00452;PF00515;PF00622;PF00789;PF01485;PF01814;PF01841;PF02148;PF02214;PF02359;PF03256;PF04721;PF05020;PF05021;PF05922;PF07707;PF09409;PF12895;PF13519;PF13589;PF13639
Group	GO:0006468	protein phosphorylation	2	4.46	4.14e-05	5.09e-04	33|425|136|3527	PF00019;PF00027;PF00063;PF00130;PF00168;PF00169;PF00240;PF00373;PF00564;PF00611;PF00688;PF00754;PF00757;PF00780;PF00989;PF01030;PF02177;PF02185;PF02259;PF02260;PF02518;PF02865;PF03165;PF04868;PF07645;PF07653;PF07679;PF08064;PF08926;PF10436;PF12924;PF12925;PF13855
Group	GO:0016569	covalent chromatin modification	2	4.49	4.32e-05	5.24e-04	30|425|119|3527	PF00076;PF00097;PF00130;PF00168;PF00179;PF00254;PF00385;PF00400;PF00515;PF00530;PF00583;PF00622;PF01088;PF01426;PF01530;PF01753;PF02008;PF02148;PF02182;PF02259;PF02260;PF02671;PF05033;PF08295;PF09247;PF11717;PF12796;PF13831;PF13832;PF13891
Group	GO:0001558	regulation of cell growth	2	4.58	5.23e-05	6.10e-04	21|425|71|3527	PF00019;PF00086;PF00179;PF00226;PF00307;PF00435;PF00688;PF00754;PF00757;PF00870;PF01030;PF01088;PF01403;PF01437;PF01562;PF07679;PF07710;PF08563;PF10409;PF12796;PF13855
Group	GO:0030097	hemopoiesis	2	4.44	5.43e-05	6.25e-04	28|425|109|3527	PF00019;PF00063;PF00130;PF00153;PF00169;PF00452;PF00605;PF00651;PF00688;PF00780;PF00870;PF01017;PF01392;PF02218;PF02865;PF05790;PF07645;PF07679;PF07686;PF07710;PF08563;PF10401;PF11971;PF12796;PF13353;PF13637;PF13855;PF14324
Group	GO:0040029	regulation of gene expression, epigenetic	2	4.50	5.86e-05	6.58e-04	23|425|82|3527	PF00179;PF00270;PF00271;PF00385;PF00400;PF00567;PF01088;PF01426;PF02008;PF02182;PF02463;PF02881;PF04408;PF05033;PF06464;PF08210;PF09416;PF12047;PF12796;PF12872;PF12933;PF12934;PF13086
Group	GO:0051241	negative regulation of multicellular organismal process	2	4.52	6.83e-05	7.32e-04	20|425|67|3527	PF00019;PF00086;PF00122;PF00169;PF00240;PF00651;PF00688;PF00689;PF00690;PF00702;PF00969;PF01017;PF01391;PF01699;PF02865;PF06741;PF07525;PF07645;PF10409;PF12796
Group	GO:0007610	behavior	2	4.29	6.76e-05	7.32e-04	35|425|151|3527	PF00027;PF00057;PF00063;PF00076;PF00122;PF00130;PF00168;PF00282;PF00307;PF00435;PF00530;PF00564;PF00630;PF00651;PF00689;PF00690;PF00702;PF00970;PF00989;PF01017;PF01082;PF01465;PF01562;PF01699;PF02177;PF02214;PF02865;PF03712;PF07653;PF12796;PF12924;PF12925;PF13639;PF13716;PF13855
Group	GO:0006304	DNA modification	2	4.63	7.87e-05	8.14e-04	15|425|43|3527	PF00270;PF00271;PF00567;PF01426;PF02008;PF02182;PF04408;PF05033;PF06464;PF08210;PF12047;PF12796;PF12872;PF12933;PF12934
Group	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2	4.63	7.87e-05	8.14e-04	15|425|43|3527	PF00019;PF00086;PF00093;PF00094;PF00683;PF00688;PF00870;PF00884;PF01392;PF03165;PF07645;PF08563;PF09289;PF12548;PF12796
Group	GO:0008285	negative regulation of cell proliferation	2	4.35	8.08e-05	8.27e-04	26|425|100|3527	PF00019;PF00350;PF00373;PF00688;PF00754;PF00870;PF00884;PF00969;PF01017;PF01391;PF01753;PF02145;PF02865;PF03165;PF07679;PF07686;PF07710;PF08563;PF09379;PF09380;PF10409;PF10524;PF10608;PF12548;PF13716;PF13733
Group	GO:0007015	actin filament organization	2	4.45	8.90e-05	9.01e-04	19|425|63|3527	PF00063;PF00241;PF00307;PF00373;PF00400;PF00611;PF00630;PF02181;PF02214;PF06346;PF06367;PF06371;PF07653;PF09058;PF09379;PF09380;PF10409;PF10608;PF12796
Group	GO:0010608	posttranscriptional regulation of gene expression	2	4.25	9.57e-05	9.58e-04	29|425|118|3527	PF00019;PF00076;PF00240;PF00270;PF00271;PF00307;PF00567;PF00630;PF00642;PF00757;PF01030;PF02148;PF02177;PF02463;PF02881;PF02985;PF05773;PF07973;PF08246;PF08662;PF09416;PF10409;PF12701;PF12872;PF12924;PF12925;PF13086;PF13405;PF14259
Group	GO:0051052	regulation of DNA metabolic process	2	4.36	1.02e-04	1.00e-03	21|425|74|3527	PF00019;PF00149;PF00179;PF00270;PF00271;PF00515;PF00651;PF00688;PF00870;PF01336;PF01391;PF01624;PF01751;PF02463;PF06733;PF07679;PF07710;PF08563;PF12756;PF12895;PF13086
Group	GO:0010740	positive regulation of intracellular protein kinase cascade	2	4.36	1.02e-04	1.00e-03	21|425|74|3527	PF00019;PF00020;PF00122;PF00130;PF00179;PF00240;PF00630;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF01030;PF01391;PF01485;PF02218;PF07653;PF07679;PF12763
Group	GO:0007411	axon guidance	2	4.29	1.17e-04	1.13e-03	22|425|80|3527	PF00052;PF00307;PF00435;PF00630;PF00651;PF00754;PF00778;PF00780;PF01391;PF01403;PF01437;PF01833;PF02148;PF02177;PF03165;PF07645;PF07679;PF08736;PF10524;PF12924;PF12925;PF13855
Group	GO:0030705	cytoskeleton-dependent intracellular transport	2	4.41	1.42e-04	1.30e-03	15|425|45|3527	PF00063;PF00169;PF00307;PF00400;PF00435;PF00928;PF00989;PF01217;PF01602;PF02177;PF06480;PF11413;PF12924;PF12925;PF13405
Group	GO:0048732	gland development	2	4.23	1.44e-04	1.30e-03	22|425|81|3527	PF00122;PF00702;PF00754;PF00757;PF00870;PF00989;PF01017;PF01030;PF01391;PF01403;PF01553;PF01562;PF02198;PF02199;PF02865;PF03489;PF05184;PF07679;PF07686;PF08736;PF10409;PF13716
Group	GO:0002252	immune effector process	2	4.19	1.44e-04	1.30e-03	24|425|92|3527	PF00057;PF00059;PF00130;PF00270;PF00271;PF00605;PF00870;PF00969;PF01391;PF01624;PF01909;PF02138;PF02463;PF02881;PF07645;PF07679;PF07686;PF08246;PF08563;PF10401;PF10409;PF13353;PF13639;PF13855
Group	GO:0006913	nucleocytoplasmic transport	2	4.21	1.67e-04	1.44e-03	20|425|71|3527	PF00019;PF00076;PF00270;PF00271;PF00638;PF00688;PF00870;PF01017;PF01412;PF02145;PF02865;PF02985;PF03810;PF07645;PF08389;PF08506;PF08563;PF11957;PF12796;PF13405
Group	GO:0001817	regulation of cytokine production	2	4.16	1.75e-04	1.49e-03	22|425|82|3527	PF00019;PF00020;PF00059;PF00076;PF00130;PF00240;PF00271;PF00605;PF00622;PF00642;PF00651;PF00688;PF00969;PF01017;PF01391;PF02865;PF07686;PF10401;PF11648;PF12796;PF13353;PF13855
Group	GO:0035107	appendage morphogenesis	2	4.07	2.06e-04	1.63e-03	24|425|94|3527	PF00057;PF00063;PF00076;PF00130;PF00168;PF00307;PF00373;PF00435;PF00452;PF00651;PF00870;PF00884;PF01426;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF09379;PF12548;PF12796;PF13855;PF14259
Group	GO:0010942	positive regulation of cell death	2	4.01	2.06e-04	1.63e-03	28|425|117|3527	PF00019;PF00020;PF00169;PF00240;PF00270;PF00271;PF00307;PF00452;PF00605;PF00688;PF00870;PF01017;PF01302;PF01335;PF01391;PF01392;PF01585;PF02259;PF02260;PF02865;PF06733;PF07653;PF07679;PF07710;PF08246;PF08563;PF10409;PF13716
Group	GO:0009895	negative regulation of catabolic process	2	4.47	2.37e-04	1.78e-03	10|425|24|3527	PF00076;PF00240;PF00307;PF00630;PF00789;PF01335;PF02148;PF02259;PF02260;PF11977
Group	GO:0009798	axis specification	2	4.18	2.48e-04	1.84e-03	16|425|52|3527	PF00057;PF00063;PF00076;PF00130;PF00168;PF00400;PF00564;PF00567;PF00622;PF00651;PF00778;PF03165;PF05033;PF07525;PF12872;PF14259
Group	GO:0001763	morphogenesis of a branching structure	2	4.06	2.73e-04	2.01e-03	19|425|68|3527	PF00019;PF00045;PF00130;PF00307;PF00413;PF00435;PF00564;PF00688;PF00754;PF00870;PF01403;PF01437;PF01471;PF01833;PF07645;PF07653;PF07679;PF08246;PF13855
Group	GO:0006066	alcohol metabolic process	2	3.99	2.75e-04	2.01e-03	23|425|90|3527	PF00019;PF00027;PF00057;PF00109;PF00205;PF00282;PF00432;PF00501;PF00535;PF00688;PF00698;PF01066;PF01082;PF01565;PF01663;PF02177;PF02801;PF03712;PF03765;PF07645;PF08659;PF12924;PF12925
Group	GO:0008544	epidermis development	2	4.00	3.09e-04	2.21e-03	20|425|74|3527	PF00019;PF00063;PF00093;PF00122;PF00373;PF00400;PF00622;PF00688;PF00689;PF00702;PF00757;PF00870;PF01030;PF01391;PF01392;PF01565;PF06733;PF07679;PF12796;PF13855
Group	GO:0001654	eye development	2	3.88	3.21e-04	2.24e-03	27|425|114|3527	PF00019;PF00053;PF00063;PF00130;PF00168;PF00246;PF00373;PF00400;PF00415;PF00452;PF00564;PF00567;PF00618;PF00651;PF00688;PF01017;PF01392;PF01602;PF02865;PF07679;PF08736;PF09379;PF09380;PF10409;PF12872;PF13716;PF14324
Group	GO:0048569	post-embryonic organ development	2	3.93	3.28e-04	2.25e-03	23|425|91|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00452;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF09379;PF12796;PF13855;PF14259
Group	GO:0006605	protein targeting	2	3.86	3.25e-04	2.25e-03	28|425|120|3527	PF00019;PF00168;PF00226;PF00307;PF00432;PF00435;PF00515;PF00638;PF00675;PF00688;PF00870;PF01017;PF01428;PF02145;PF02865;PF02881;PF02985;PF03810;PF04695;PF05193;PF07645;PF08389;PF08506;PF08563;PF10559;PF12796;PF13405;PF13855
Group	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2	3.90	3.67e-04	2.48e-03	22|425|86|3527	PF00019;PF00130;PF00168;PF00169;PF00307;PF00618;PF00688;PF00754;PF00757;PF00884;PF01017;PF01030;PF02145;PF02865;PF07525;PF07645;PF07653;PF07679;PF07686;PF10409;PF12548;PF13855
Group	GO:0008283	cell proliferation	2	3.78	3.66e-04	2.48e-03	32|425|145|3527	PF00019;PF00020;PF00027;PF00076;PF00086;PF00130;PF00254;PF00452;PF00501;PF00530;PF00564;PF00688;PF00870;PF01017;PF01392;PF01433;PF02148;PF02182;PF02198;PF02865;PF03165;PF07653;PF07679;PF07686;PF07710;PF08506;PF08563;PF09058;PF10409;PF10608;PF12148;PF13639
Group	GO:0048737	imaginal disc-derived appendage development	2	3.99	3.83e-04	2.56e-03	17|425|59|3527	PF00063;PF00076;PF00130;PF00307;PF00373;PF00435;PF00651;PF01426;PF01476;PF01833;PF03165;PF07534;PF07645;PF09379;PF12796;PF13855;PF14259
Group	GO:0051240	positive regulation of multicellular organismal process	2	3.84	4.06e-04	2.67e-03	24|425|98|3527	PF00019;PF00027;PF00122;PF00130;PF00168;PF00169;PF00271;PF00605;PF00688;PF00689;PF00690;PF00702;PF01017;PF01391;PF01699;PF02865;PF07645;PF07679;PF10401;PF11648;PF12796;PF13353;PF13716;PF13855
Group	GO:0016337	cell-cell adhesion	2	4.02	4.11e-04	2.69e-03	15|425|49|3527	PF00059;PF00122;PF00169;PF00373;PF00688;PF00689;PF00690;PF00702;PF00884;PF07679;PF07686;PF09058;PF10608;PF12548;PF13855
Group	GO:0006955	immune response	2	3.74	4.25e-04	2.72e-03	31|425|140|3527	PF00057;PF00059;PF00085;PF00130;PF00240;PF00271;PF00350;PF00605;PF00651;PF00870;PF00969;PF01017;PF01033;PF01391;PF01624;PF02263;PF02865;PF03172;PF07645;PF07679;PF07686;PF08246;PF08563;PF10401;PF10409;PF11648;PF11971;PF12697;PF12796;PF13639;PF13855
Group	GO:0032446	protein modification by small protein conjugation	2	3.78	4.33e-04	2.75e-03	27|425|116|3527	PF00097;PF00168;PF00179;PF00240;PF00415;PF00622;PF00630;PF00651;PF00899;PF01485;PF01814;PF02148;PF02182;PF02214;PF02225;PF03256;PF05773;PF07707;PF10585;PF12796;PF12894;PF12895;PF12906;PF13599;PF13637;PF13639;PF14324
Group	GO:0051248	negative regulation of protein metabolic process	2	3.76	4.35e-04	2.75e-03	28|425|122|3527	PF00019;PF00076;PF00226;PF00240;PF00307;PF00373;PF00400;PF00452;PF00630;PF00688;PF00789;PF01335;PF01391;PF01585;PF02145;PF02148;PF05773;PF07525;PF09379;PF09380;PF11934;PF11977;PF12701;PF12796;PF13405;PF13716;PF13905;PF14259
Group	GO:0007018	microtubule-based movement	2	3.91	4.77e-04	2.99e-03	17|425|60|3527	PF00063;PF00169;PF00307;PF00400;PF00435;PF00928;PF00989;PF01217;PF01302;PF01602;PF02177;PF03133;PF06480;PF11413;PF12924;PF12925;PF13405
Group	GO:0043549	regulation of kinase activity	2	3.70	4.93e-04	3.07e-03	30|425|135|3527	PF00019;PF00027;PF00097;PF00169;PF00240;PF00400;PF00415;PF00564;PF00688;PF00778;PF00780;PF01391;PF01392;PF01585;PF02145;PF02177;PF04868;PF07525;PF07645;PF07653;PF07679;PF09379;PF09380;PF11934;PF12796;PF12924;PF12925;PF13405;PF13716;PF13855
Group	GO:0044057	regulation of system process	2	3.68	5.79e-04	3.49e-03	27|425|118|3527	PF00019;PF00027;PF00063;PF00122;PF00130;PF00168;PF00169;PF00254;PF00258;PF00435;PF00618;PF00667;PF00688;PF00689;PF00690;PF00702;PF01391;PF01699;PF01833;PF02214;PF03226;PF07653;PF07679;PF07686;PF10608;PF12796;PF13855
Group	GO:0045927	positive regulation of growth	2	3.83	5.89e-04	3.52e-03	17|425|61|3527	PF00063;PF00072;PF00133;PF00168;PF00169;PF00270;PF00271;PF00630;PF00757;PF00989;PF01017;PF01030;PF02865;PF03165;PF12796;PF13405;PF13716
Group	GO:1901214	regulation of neuron death	2	3.84	6.62e-04	3.91e-03	15|425|51|3527	PF00082;PF00168;PF00169;PF00452;PF00630;PF00870;PF01392;PF05922;PF07653;PF07679;PF07710;PF08563;PF12763;PF13716;PF13855
Group	GO:0033365	protein localization to organelle	2	3.64	6.67e-04	3.91e-03	26|425|113|3527	PF00019;PF00168;PF00226;PF00240;PF00307;PF00350;PF00435;PF00515;PF00638;PF00675;PF00688;PF00870;PF00999;PF01017;PF02145;PF02865;PF02881;PF03810;PF04695;PF05193;PF07645;PF08389;PF08506;PF08563;PF10559;PF12796
Group	GO:0000279	M phase	2	3.52	8.48e-04	4.83e-03	29|425|133|3527	PF00130;PF00149;PF00179;PF00240;PF00270;PF00271;PF00307;PF00385;PF00400;PF00567;PF00630;PF00651;PF00780;PF01624;PF01715;PF01751;PF02148;PF02259;PF02260;PF02463;PF02518;PF04408;PF07679;PF07686;PF07707;PF12765;PF12796;PF12895;PF13589
Group	GO:0031589	cell-substrate adhesion	2	3.83	8.75e-04	4.88e-03	12|425|37|3527	PF00086;PF00094;PF00362;PF01391;PF01392;PF01826;PF06119;PF07645;PF07686;PF08725;PF08742;PF13637
Group	GO:0072657	protein localization to membrane	2	3.83	8.75e-04	4.88e-03	12|425|37|3527	PF00053;PF00169;PF00611;PF00630;PF01391;PF01392;PF07653;PF07679;PF10608;PF12796;PF13405;PF13637
Group	GO:0042176	regulation of protein catabolic process	2	3.79	8.85e-04	4.88e-03	13|425|42|3527	PF00240;PF00307;PF00373;PF00400;PF00515;PF00630;PF00778;PF00789;PF01335;PF02148;PF07525;PF11977;PF14324
Group	GO:0010769	regulation of cell morphogenesis involved in differentiation	2	3.67	8.84e-04	4.88e-03	17|425|63|3527	PF00019;PF00086;PF00307;PF00435;PF00515;PF00688;PF00780;PF01403;PF01437;PF01562;PF01833;PF02181;PF03165;PF06367;PF06371;PF07679;PF13855
Group	GO:0017038	protein import	2	3.67	8.84e-04	4.88e-03	17|425|63|3527	PF00019;PF00226;PF00400;PF00515;PF00638;PF00675;PF00688;PF00870;PF01017;PF02145;PF02865;PF03810;PF04695;PF05193;PF07645;PF08563;PF12796
Group	GO:0071310	cellular response to organic substance	2	3.40	9.18e-04	4.93e-03	45|425|237|3527	PF00019;PF00020;PF00072;PF00076;PF00093;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00400;PF00452;PF00583;PF00605;PF00622;PF00688;PF00754;PF00757;PF00969;PF01017;PF01030;PF01391;PF01909;PF02199;PF02263;PF02463;PF02518;PF02760;PF02865;PF02881;PF03165;PF03489;PF05184;PF07525;PF07653;PF07679;PF07686;PF10401;PF10409;PF13639;PF13855
Group	GO:0050890	cognition	2	3.66	9.61e-04	5.00e-03	16|425|58|3527	PF00057;PF00122;PF00530;PF00564;PF00630;PF00689;PF00690;PF00702;PF01699;PF02177;PF04756;PF07653;PF12924;PF12925;PF13639;PF13716
Group	GO:1900542	regulation of purine nucleotide metabolic process	2	3.57	9.67e-04	5.00e-03	21|425|86|3527	PF00027;PF00063;PF00130;PF00168;PF00169;PF00226;PF00307;PF00610;PF00611;PF00618;PF00780;PF01403;PF01412;PF01437;PF02145;PF06920;PF07653;PF11971;PF13716;PF13855;PF14429
Group	GO:0051216	cartilage development	2	3.68	1.13e-03	5.73e-03	13|425|43|3527	PF00019;PF00052;PF00053;PF00057;PF00093;PF00688;PF00884;PF01391;PF03165;PF07645;PF07679;PF10524;PF12548
Group	GO:0051494	negative regulation of cytoskeleton organization	2	3.72	1.14e-03	5.75e-03	12|425|38|3527	PF00086;PF00241;PF00254;PF00307;PF00400;PF00435;PF00622;PF01302;PF07653;PF08953;PF08954;PF12796
Group	GO:0032844	regulation of homeostatic process	2	3.55	1.16e-03	5.83e-03	18|425|70|3527	PF00019;PF00057;PF00168;PF00179;PF00254;PF00307;PF00452;PF00622;PF00688;PF00969;PF01017;PF02198;PF02865;PF03226;PF12796;PF13405;PF13637;PF13716
Group	GO:0044265	cellular macromolecule catabolic process	2	3.34	1.21e-03	6.00e-03	37|425|187|3527	PF00082;PF00085;PF00097;PF00168;PF00179;PF00226;PF00240;PF00271;PF00400;PF00452;PF00515;PF00622;PF00642;PF00789;PF01485;PF01624;PF01814;PF01909;PF02148;PF02214;PF02260;PF02359;PF03167;PF03256;PF05020;PF05021;PF05922;PF06058;PF07707;PF09416;PF12842;PF12895;PF13086;PF13519;PF13589;PF13639;PF14259
Group	GO:0032535	regulation of cellular component size	2	3.53	1.29e-03	6.34e-03	17|425|65|3527	PF00130;PF00168;PF00169;PF00241;PF00307;PF00400;PF00435;PF01403;PF01437;PF01562;PF02145;PF02181;PF07653;PF07679;PF08953;PF10409;PF13855
Group	GO:0060249	anatomical structure homeostasis	2	3.45	1.33e-03	6.44e-03	21|425|88|3527	PF00059;PF00082;PF00270;PF00271;PF00373;PF00435;PF00452;PF01336;PF01391;PF02259;PF02260;PF02463;PF02765;PF06733;PF07679;PF07686;PF08246;PF08736;PF09379;PF09380;PF12796
Group	GO:0045596	negative regulation of cell differentiation	2	3.39	1.33e-03	6.44e-03	26|425|118|3527	PF00019;PF00086;PF00307;PF00515;PF00605;PF00630;PF00642;PF00688;PF00778;PF00780;PF00870;PF01017;PF01391;PF01403;PF02177;PF02463;PF02865;PF03165;PF07645;PF07679;PF08563;PF12796;PF12924;PF12925;PF13716;PF14259
Group	GO:0016358	dendrite development	2	3.58	1.36e-03	6.58e-03	14|425|49|3527	PF00024;PF00053;PF00307;PF00435;PF00780;PF01044;PF02177;PF02671;PF07653;PF07679;PF08295;PF12796;PF12924;PF12925
Group	GO:0032970	regulation of actin filament-based process	2	3.49	1.56e-03	7.35e-03	15|425|55|3527	PF00086;PF00130;PF00168;PF00169;PF00241;PF00373;PF00400;PF00610;PF00611;PF02181;PF07653;PF07686;PF08953;PF08954;PF12796
Group	GO:0043408	regulation of MAPK cascade	2	3.35	1.77e-03	8.00e-03	20|425|84|3527	PF00020;PF00097;PF00130;PF00168;PF00169;PF00373;PF00757;PF00778;PF00780;PF01030;PF01391;PF01392;PF02199;PF03489;PF05184;PF07653;PF07679;PF09379;PF09380;PF13855
Group	GO:0009615	response to virus	2	3.49	1.80e-03	8.05e-03	13|425|45|3527	PF00270;PF00271;PF00350;PF00452;PF00515;PF00605;PF01909;PF02463;PF02881;PF10401;PF11648;PF13353;PF13855
Group	GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	2	3.49	1.80e-03	8.05e-03	13|425|45|3527	PF00122;PF00179;PF00240;PF00630;PF00689;PF00690;PF00702;PF01017;PF01391;PF01485;PF02865;PF12796;PF13405
Group	GO:0007600	sensory perception	2	3.32	1.81e-03	8.05e-03	22|425|96|3527	PF00024;PF00027;PF00053;PF00063;PF00122;PF00307;PF00350;PF00373;PF00415;PF00689;PF00690;PF00702;PF01391;PF01477;PF07653;PF07679;PF07686;PF09379;PF12424;PF12796;PF13385;PF13637
Group	GO:0019216	regulation of lipid metabolic process	2	3.38	1.86e-03	8.23e-03	17|425|67|3527	PF00019;PF00097;PF00169;PF00400;PF00501;PF00688;PF01017;PF01391;PF02199;PF02865;PF03489;PF05184;PF07653;PF07679;PF09771;PF11934;PF12697
Group	GO:0007268	synaptic transmission	2	3.22	1.90e-03	8.39e-03	30|425|146|3527	PF00063;PF00122;PF00130;PF00168;PF00169;PF00282;PF00435;PF00622;PF00651;PF00690;PF00928;PF01044;PF01217;PF01302;PF01392;PF01504;PF01602;PF02177;PF02214;PF03165;PF07653;PF07679;PF07690;PF07707;PF10608;PF12763;PF12796;PF12924;PF12925;PF13855
Group	GO:0032270	positive regulation of cellular protein metabolic process	2	3.21	1.98e-03	8.70e-03	29|425|140|3527	PF00019;PF00057;PF00076;PF00179;PF00240;PF00373;PF00400;PF00515;PF00564;PF00688;PF00757;PF00778;PF00780;PF00870;PF01030;PF01302;PF01391;PF02218;PF04868;PF07645;PF07653;PF07679;PF07710;PF08563;PF09771;PF12763;PF13405;PF13855;PF14324
Group	GO:0031532	actin cytoskeleton reorganization	2	3.70	2.31e-03	9.68e-03	7|425|17|3527	PF00122;PF00130;PF00689;PF00690;PF00702;PF00780;PF07686
Group	GO:0030111	regulation of Wnt receptor signaling pathway	2	3.34	2.31e-03	9.68e-03	15|425|57|3527	PF00019;PF00057;PF00400;PF00688;PF00778;PF00884;PF01302;PF01391;PF01392;PF07679;PF12548;PF12796;PF13637;PF13639;PF13905
Group	GO:0009100	glycoprotein metabolic process	2	3.23	2.40e-03	9.87e-03	20|425|86|3527	PF00085;PF00094;PF00122;PF00515;PF00534;PF00535;PF00702;PF00884;PF01841;PF02434;PF03155;PF04721;PF04756;PF04810;PF04811;PF09409;PF10250;PF12548;PF13733;PF13855
Group	GO:0045597	positive regulation of cell differentiation	2	3.21	2.39e-03	9.87e-03	22|425|98|3527	PF00019;PF00086;PF00093;PF00130;PF00168;PF00400;PF00530;PF00564;PF00688;PF01017;PF01391;PF01403;PF01437;PF02198;PF02865;PF03165;PF07525;PF07645;PF07679;PF12796;PF13405;PF13855
Group	GO:0018958	phenol-containing compound metabolic process	3	5.69	7.83e-06	1.27e-04	11|425|21|3527	PF00019;PF00109;PF00282;PF00501;PF00688;PF00698;PF01082;PF02801;PF03712;PF04389;PF08659
Group	GO:0051017	actin filament bundle assembly	3	5.36	1.59e-05	2.25e-04	12|425|26|3527	PF00063;PF00307;PF00373;PF00611;PF02181;PF02214;PF06367;PF06371;PF07653;PF09379;PF09380;PF12796
Group	GO:0002028	regulation of sodium ion transport	3	5.44	2.59e-05	3.46e-04	9|425|16|3527	PF00122;PF00168;PF00169;PF00307;PF00435;PF00689;PF00690;PF00702;PF13405
Group	GO:0007309	oocyte axis specification	3	5.19	4.93e-05	5.89e-04	9|425|17|3527	PF00076;PF00130;PF00564;PF00567;PF00622;PF00651;PF07525;PF12872;PF14259
Group	GO:0045639	positive regulation of myeloid cell differentiation	3	5.19	6.47e-05	7.18e-04	8|425|14|3527	PF00019;PF00130;PF00168;PF00688;PF02198;PF02865;PF12796;PF13405
Group	GO:0032479	regulation of type I interferon production	3	5.47	6.70e-05	7.32e-04	6|425|8|3527	PF00240;PF00271;PF00605;PF10401;PF11648;PF13855
Group	GO:0045822	negative regulation of heart contraction	3	5.37	1.34e-04	1.25e-03	5|425|6|3527	PF00122;PF00169;PF00689;PF00690;PF00702
Group	GO:0051220	cytoplasmic sequestering of protein	3	5.37	1.34e-04	1.25e-03	5|425|6|3527	PF00307;PF00630;PF05076;PF12470;PF12796
Group	GO:0042157	lipoprotein metabolic process	3	4.64	1.55e-04	1.37e-03	10|425|23|3527	PF00057;PF00149;PF00534;PF00535;PF01302;PF01663;PF05024;PF07645;PF08288;PF12796
Group	GO:0045747	positive regulation of Notch signaling pathway	3	4.93	1.62e-04	1.41e-03	7|425|12|3527	PF00307;PF00870;PF01017;PF02434;PF02865;PF07710;PF10358
Group	GO:0045646	regulation of erythrocyte differentiation	3	4.93	1.62e-04	1.41e-03	7|425|12|3527	PF00019;PF00307;PF00688;PF01017;PF02198;PF02865;PF12796
Group	GO:0045186	zonula adherens assembly	3	5.04	1.81e-04	1.49e-03	6|425|9|3527	PF00130;PF00169;PF00307;PF00435;PF00564;PF07653
Group	GO:0032776	DNA methylation on cytosine	3	5.04	1.81e-04	1.49e-03	6|425|9|3527	PF01426;PF02008;PF02182;PF06464;PF12047;PF12796
Group	GO:0010821	regulation of mitochondrion organization	3	5.04	1.81e-04	1.49e-03	6|425|9|3527	PF00169;PF00452;PF00870;PF07710;PF08563;PF12906
Group	GO:0032092	positive regulation of protein binding	3	5.04	1.81e-04	1.49e-03	6|425|9|3527	PF00373;PF02434;PF04382;PF08736;PF09379;PF09380
Group	GO:0048840	otolith development	3	5.41	2.08e-04	1.63e-03	4|425|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032472	Golgi calcium ion transport	3	5.41	2.08e-04	1.63e-03	4|425|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032468	Golgi calcium ion homeostasis	3	5.41	2.08e-04	1.63e-03	4|425|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0006275	regulation of DNA replication	3	4.44	2.16e-04	1.67e-03	11|425|28|3527	PF00019;PF00271;PF00515;PF00688;PF00870;PF01336;PF02463;PF08563;PF12756;PF12895;PF13086
Group	GO:0034311	diol metabolic process	3	4.67	2.22e-04	1.69e-03	8|425|16|3527	PF00019;PF00109;PF00282;PF00501;PF00688;PF00698;PF02801;PF08659
Group	GO:1901185	negative regulation of ERBB signaling pathway	3	4.67	2.22e-04	1.69e-03	8|425|16|3527	PF00168;PF01585;PF02262;PF02761;PF02762;PF07525;PF07679;PF13855
Group	GO:0001894	tissue homeostasis	3	4.47	2.37e-04	1.78e-03	10|425|24|3527	PF00059;PF00082;PF00373;PF00452;PF01391;PF07686;PF08246;PF08736;PF09379;PF09380
Group	GO:0008542	visual learning	3	4.64	3.15e-04	2.21e-03	7|425|13|3527	PF00122;PF00689;PF00690;PF00702;PF02177;PF12924;PF12925
Group	GO:0042177	negative regulation of protein catabolic process	3	4.64	3.15e-04	2.21e-03	7|425|13|3527	PF00240;PF00307;PF00630;PF00789;PF01335;PF02148;PF11977
Group	GO:0006901	vesicle coating	3	4.64	3.15e-04	2.21e-03	7|425|13|3527	PF00611;PF00651;PF00928;PF01217;PF01602;PF07651;PF07707
Group	GO:0007229	integrin-mediated signaling pathway	3	4.44	3.76e-04	2.53e-03	8|425|17|3527	PF00130;PF00169;PF00362;PF00373;PF07653;PF07965;PF08725;PF11971
Group	GO:0060742	epithelial cell differentiation involved in prostate gland development	3	4.66	4.06e-04	2.67e-03	6|425|10|3527	PF00870;PF02199;PF02865;PF03489;PF05184;PF07679
Group	GO:0000733	DNA strand renaturation	3	4.83	4.24e-04	2.72e-03	5|425|7|3527	PF00270;PF00271;PF00870;PF07710;PF08563
Group	GO:0051402	neuron apoptotic process	3	4.37	5.65e-04	3.44e-03	7|425|14|3527	PF00027;PF00870;PF02177;PF07710;PF08563;PF12924;PF12925
Group	GO:1901216	positive regulation of neuron death	3	4.37	5.65e-04	3.44e-03	7|425|14|3527	PF00452;PF00870;PF01392;PF07679;PF07710;PF08563;PF13716
Group	GO:0006505	GPI anchor metabolic process	3	4.37	5.65e-04	3.44e-03	7|425|14|3527	PF00149;PF00534;PF00535;PF01663;PF04080;PF05024;PF08288
Group	GO:0060491	regulation of cell projection assembly	3	4.17	5.78e-04	3.49e-03	9|425|22|3527	PF00063;PF00072;PF00086;PF00130;PF02181;PF02518;PF06367;PF06371;PF12796
Group	GO:0022405	hair cycle process	3	4.23	6.07e-04	3.61e-03	8|425|18|3527	PF00019;PF00688;PF00757;PF00870;PF01030;PF01391;PF01392;PF07679
Group	GO:0001778	plasma membrane repair	3	4.34	8.03e-04	4.62e-03	6|425|11|3527	PF00063;PF00168;PF00622;PF08150;PF08151;PF08165
Group	GO:0007044	cell-substrate junction assembly	3	4.34	8.03e-04	4.62e-03	6|425|11|3527	PF00052;PF00053;PF00362;PF01391;PF07965;PF08725
Group	GO:0002026	regulation of the force of heart contraction	3	4.34	8.03e-04	4.62e-03	6|425|11|3527	PF00122;PF00169;PF00689;PF00690;PF00702;PF01699
Group	GO:0030336	negative regulation of cell migration	3	4.00	8.50e-04	4.83e-03	9|425|23|3527	PF00019;PF00086;PF00688;PF00884;PF01391;PF07546;PF10409;PF12548;PF13855
Group	GO:0055071	manganese ion homeostasis	3	4.67	9.42e-04	4.93e-03	4|425|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0051238	sequestering of metal ion	3	4.67	9.42e-04	4.93e-03	4|425|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0042476	odontogenesis	3	4.03	9.40e-04	4.93e-03	8|425|19|3527	PF00019;PF00373;PF00688;PF00870;PF01391;PF07679;PF09379;PF09380
Group	GO:0007050	cell cycle arrest	3	4.03	9.40e-04	4.93e-03	8|425|19|3527	PF00019;PF00350;PF00605;PF00688;PF00870;PF07645;PF07710;PF08563
Group	GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator	3	4.39	1.02e-03	5.18e-03	5|425|8|3527	PF00040;PF00059;PF00270;PF00271;PF01753
Group	GO:0034121	regulation of toll-like receptor signaling pathway	3	4.39	1.02e-03	5.18e-03	5|425|8|3527	PF00605;PF07679;PF10401;PF12796;PF13353
Group	GO:0030638	polyketide metabolic process	3	4.39	1.02e-03	5.18e-03	5|425|8|3527	PF00109;PF00698;PF02801;PF08242;PF08659
Group	GO:0007088	regulation of mitosis	3	3.84	1.22e-03	6.00e-03	9|425|24|3527	PF00019;PF00270;PF00271;PF00515;PF00688;PF02148;PF07679;PF07686;PF12895
Group	GO:0007565	female pregnancy	3	3.84	1.22e-03	6.00e-03	9|425|24|3527	PF00045;PF00053;PF00413;PF00754;PF01017;PF01335;PF01471;PF02865;PF07686
Group	GO:0045931	positive regulation of mitotic cell cycle	3	3.85	1.40e-03	6.70e-03	8|425|20|3527	PF00130;PF00168;PF01017;PF01426;PF02177;PF02865;PF12924;PF12925
Group	GO:0006885	regulation of pH	3	3.85	1.40e-03	6.70e-03	8|425|20|3527	PF00122;PF00400;PF00689;PF00690;PF00702;PF00999;PF01496;PF13405
Group	GO:0019954	asexual reproduction	3	4.04	1.44e-03	6.82e-03	6|425|12|3527	PF00063;PF00072;PF00169;PF00618;PF02518;PF09335
Group	GO:0001935	endothelial cell proliferation	3	4.04	1.44e-03	6.82e-03	6|425|12|3527	PF00019;PF00530;PF00688;PF07653;PF09058;PF10608
Group	GO:0007561	imaginal disc eversion	3	4.68	1.74e-03	7.89e-03	3|425|3|3527	PF00045;PF00413;PF01471
Group	GO:0043967	histone H4 acetylation	3	4.01	2.07e-03	8.73e-03	5|425|9|3527	PF00400;PF01530;PF13831;PF13832;PF13891
Group	GO:0006611	protein export from nucleus	3	4.01	2.07e-03	8.73e-03	5|425|9|3527	PF00019;PF00688;PF03810;PF08389;PF13405
Group	GO:0060571	morphogenesis of an epithelial fold	3	4.01	2.07e-03	8.73e-03	5|425|9|3527	PF00130;PF00757;PF00870;PF01030;PF07679
Group	GO:0007176	regulation of epidermal growth factor-activated receptor activity	3	4.01	2.07e-03	8.73e-03	5|425|9|3527	PF01585;PF02177;PF07525;PF12924;PF12925
Group	GO:2001252	positive regulation of chromosome organization	3	4.01	2.07e-03	8.73e-03	5|425|9|3527	PF00400;PF00515;PF00870;PF07710;PF08563
Group	GO:0007589	body fluid secretion	3	4.01	2.07e-03	8.73e-03	5|425|9|3527	PF00122;PF00702;PF01017;PF01553;PF02865
Group	GO:0010463	mesenchymal cell proliferation	3	4.01	2.07e-03	8.73e-03	5|425|9|3527	PF00019;PF00688;PF01017;PF02865;PF07679
Group	GO:0002831	regulation of response to biotic stimulus	3	3.68	2.03e-03	8.73e-03	8|425|21|3527	PF00072;PF00130;PF00168;PF01217;PF01602;PF07686;PF12796;PF13855
Group	GO:0051607	defense response to virus	3	3.55	2.33e-03	9.72e-03	9|425|26|3527	PF00270;PF00271;PF00605;PF01909;PF02463;PF02881;PF10401;PF13353;PF13855
Group	GO:0046823	negative regulation of nucleocytoplasmic transport	3	3.78	2.41e-03	9.87e-03	6|425|13|3527	PF01302;PF05076;PF12470;PF12796;PF13405;PF13716
Group	GO:0050885	neuromuscular process controlling balance	3	3.78	2.41e-03	9.87e-03	6|425|13|3527	PF00063;PF02177;PF07653;PF12796;PF12924;PF12925
Group	GO:0008156	negative regulation of DNA replication	4	5.37	1.34e-04	1.25e-03	5|425|6|3527	PF00019;PF00271;PF00688;PF00870;PF08563
Group	GO:0010165	response to X-ray	4	5.41	2.08e-04	1.63e-03	4|425|4|3527	PF00270;PF00870;PF07710;PF08563
Group	GO:0000060	protein import into nucleus, translocation	4	4.83	4.24e-04	2.72e-03	5|425|7|3527	PF00019;PF00688;PF00870;PF08563;PF12796
Group	GO:0097040	phthiocerol biosynthetic process	4	4.67	9.42e-04	4.93e-03	4|425|5|3527	PF00109;PF00698;PF02801;PF08659
Group	GO:0097041	phenolic phthiocerol biosynthetic process	4	4.67	9.42e-04	4.93e-03	4|425|5|3527	PF00109;PF00698;PF02801;PF08659
Group	GO:0045648	positive regulation of erythrocyte differentiation	4	4.67	9.42e-04	4.93e-03	4|425|5|3527	PF00019;PF00688;PF02198;PF12796
Group	GO:0046902	regulation of mitochondrial membrane permeability	4	4.67	9.42e-04	4.93e-03	4|425|5|3527	PF00452;PF00870;PF07710;PF08563
Group	GO:0090191	negative regulation of branching involved in ureteric bud morphogenesis	4	4.68	1.74e-03	7.89e-03	3|425|3|3527	PF00019;PF00086;PF00688
Group	GO:0035307	positive regulation of protein dephosphorylation	4	4.68	1.74e-03	7.89e-03	3|425|3|3527	PF00019;PF00688;PF09771
Group	GO:0051563	smooth endoplasmic reticulum calcium ion homeostasis	4	4.68	1.74e-03	7.89e-03	3|425|3|3527	PF02177;PF12924;PF12925
Group	GO:0043934	sporulation	4	4.68	1.74e-03	7.89e-03	3|425|3|3527	PF00072;PF00789;PF02518
Group	GO:0040021	hermaphrodite germ-line sex determination	4	4.68	1.74e-03	7.89e-03	3|425|3|3527	PF00076;PF00270;PF00271
